<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.1d3 20150301//EN" "http://jats.nlm.nih.gov/publishing/1.1d3/JATS-journalpublishing1.dtd">
<article article-type="research-article" dtd-version="1.1d3" xml:lang="en" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">
<front>
<journal-meta>
<journal-id journal-id-type="nlm-ta">PLoS ONE</journal-id>
<journal-id journal-id-type="publisher-id">plos</journal-id>
<journal-id journal-id-type="pmc">plosone</journal-id>
<journal-title-group>
<journal-title>PLOS ONE</journal-title>
</journal-title-group>
<issn pub-type="epub">1932-6203</issn>
<publisher>
<publisher-name>Public Library of Science</publisher-name>
<publisher-loc>San Francisco, CA USA</publisher-loc>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="doi">10.1371/journal.pone.0301194</article-id>
<article-id pub-id-type="publisher-id">PONE-D-23-28781</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Study Protocol</subject>
</subj-group>
<subj-group subj-group-type="Discipline-v3">
<subject>Biology and life sciences</subject><subj-group><subject>Anatomy</subject><subj-group><subject>Musculoskeletal system</subject><subj-group><subject>Skeleton</subject><subj-group><subject>Pelvis</subject><subj-group><subject>Hip</subject></subj-group></subj-group></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3">
<subject>Medicine and health sciences</subject><subj-group><subject>Anatomy</subject><subj-group><subject>Musculoskeletal system</subject><subj-group><subject>Skeleton</subject><subj-group><subject>Pelvis</subject><subj-group><subject>Hip</subject></subj-group></subj-group></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3">
<subject>Medicine and health sciences</subject><subj-group><subject>Surgical and invasive medical procedures</subject></subj-group></subj-group><subj-group subj-group-type="Discipline-v3">
<subject>Medicine and health sciences</subject><subj-group><subject>Surgical and invasive medical procedures</subject><subj-group><subject>Musculoskeletal system procedures</subject><subj-group><subject>Arthroscopy</subject></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3">
<subject>Medicine and health sciences</subject><subj-group><subject>Clinical medicine</subject><subj-group><subject>Clinical trials</subject><subj-group><subject>Randomized controlled trials</subject></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3">
<subject>Medicine and health sciences</subject><subj-group><subject>Pharmacology</subject><subj-group><subject>Drug research and development</subject><subj-group><subject>Clinical trials</subject><subj-group><subject>Randomized controlled trials</subject></subj-group></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3">
<subject>Research and analysis methods</subject><subj-group><subject>Clinical trials</subject><subj-group><subject>Randomized controlled trials</subject></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3">
<subject>Research and analysis methods</subject><subj-group><subject>Research design</subject><subj-group><subject>Qualitative studies</subject></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3">
<subject>Medicine and health sciences</subject><subj-group><subject>Clinical medicine</subject><subj-group><subject>Signs and symptoms</subject><subj-group><subject>Pain</subject></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3">
<subject>Research and analysis methods</subject><subj-group><subject>Research assessment</subject><subj-group><subject>Systematic reviews</subject></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3">
<subject>Medicine and health sciences</subject><subj-group><subject>Clinical medicine</subject><subj-group><subject>Signs and symptoms</subject><subj-group><subject>Pain</subject><subj-group><subject>Myalgia</subject></subj-group></subj-group></subj-group></subj-group></subj-group></article-categories>
<title-group>
<article-title>PREHAB FAI- Prehabilitation for patients undergoing arthroscopic hip surgery for Femoroacetabular Impingement Syndrome -Protocol for an assessor blinded randomised controlled feasibility study</article-title>
<alt-title alt-title-type="running-head">Prehabilitation for patients undergoing hip arthroscopy for Femoroacetabular Impingement Syndrome</alt-title>
</title-group>
<contrib-group>
<contrib contrib-type="author" equal-contrib="yes" xlink:type="simple">
<contrib-id authenticated="true" contrib-id-type="orcid">https://orcid.org/0000-0003-4477-2822</contrib-id>
<name name-style="western">
<surname>Punnoose</surname>
<given-names>Anuj</given-names>
</name>
<role content-type="http://credit.niso.org/contributor-roles/conceptualization/">Conceptualization</role>
<role content-type="http://credit.niso.org/contributor-roles/funding-acquisition/">Funding acquisition</role>
<role content-type="http://credit.niso.org/contributor-roles/methodology/">Methodology</role>
<role content-type="http://credit.niso.org/contributor-roles/project-administration/">Project administration</role>
<role content-type="http://credit.niso.org/contributor-roles/resources/">Resources</role>
<role content-type="http://credit.niso.org/contributor-roles/validation/">Validation</role>
<role content-type="http://credit.niso.org/contributor-roles/visualization/">Visualization</role>
<role content-type="http://credit.niso.org/contributor-roles/writing-original-draft/">Writing – original draft</role>
<role content-type="http://credit.niso.org/contributor-roles/writing-review-editing/">Writing – review &amp; editing</role>
<xref ref-type="aff" rid="aff001"><sup>1</sup></xref>
<xref ref-type="aff" rid="aff002"><sup>2</sup></xref>
</contrib>
<contrib contrib-type="author" equal-contrib="yes" xlink:type="simple">
<name name-style="western">
<surname>Claydon-Mueller</surname>
<given-names>Leica</given-names>
</name>
<role content-type="http://credit.niso.org/contributor-roles/conceptualization/">Conceptualization</role>
<role content-type="http://credit.niso.org/contributor-roles/methodology/">Methodology</role>
<role content-type="http://credit.niso.org/contributor-roles/project-administration/">Project administration</role>
<role content-type="http://credit.niso.org/contributor-roles/supervision/">Supervision</role>
<role content-type="http://credit.niso.org/contributor-roles/validation/">Validation</role>
<role content-type="http://credit.niso.org/contributor-roles/visualization/">Visualization</role>
<role content-type="http://credit.niso.org/contributor-roles/writing-review-editing/">Writing – review &amp; editing</role>
<xref ref-type="aff" rid="aff002"><sup>2</sup></xref>
</contrib>
<contrib contrib-type="author" xlink:type="simple">
<name name-style="western">
<surname>Rushton</surname>
<given-names>Alison</given-names>
</name>
<role content-type="http://credit.niso.org/contributor-roles/conceptualization/">Conceptualization</role>
<role content-type="http://credit.niso.org/contributor-roles/methodology/">Methodology</role>
<role content-type="http://credit.niso.org/contributor-roles/supervision/">Supervision</role>
<role content-type="http://credit.niso.org/contributor-roles/validation/">Validation</role>
<role content-type="http://credit.niso.org/contributor-roles/writing-review-editing/">Writing – review &amp; editing</role>
<xref ref-type="aff" rid="aff003"><sup>3</sup></xref>
</contrib>
<contrib contrib-type="author" corresp="yes" xlink:type="simple">
<name name-style="western">
<surname>Khanduja</surname>
<given-names>Vikas</given-names>
</name>
<role content-type="http://credit.niso.org/contributor-roles/conceptualization/">Conceptualization</role>
<role content-type="http://credit.niso.org/contributor-roles/methodology/">Methodology</role>
<role content-type="http://credit.niso.org/contributor-roles/supervision/">Supervision</role>
<role content-type="http://credit.niso.org/contributor-roles/validation/">Validation</role>
<role content-type="http://credit.niso.org/contributor-roles/visualization/">Visualization</role>
<role content-type="http://credit.niso.org/contributor-roles/writing-review-editing/">Writing – review &amp; editing</role>
<xref ref-type="aff" rid="aff004"><sup>4</sup></xref>
<xref ref-type="corresp" rid="cor001">*</xref>
</contrib>
</contrib-group>
<aff id="aff001"><label>1</label> <addr-line>Young Adult Hip Service &amp; Physiotherapy Department, Addenbrooke’s- Cambridge University Hospitals NHS Foundation Trust, Cambridge, United Kingdom</addr-line></aff>
<aff id="aff002"><label>2</label> <addr-line>School of Allied Health, Anglia Ruskin University, Cambridge, United Kingdom</addr-line></aff>
<aff id="aff003"><label>3</label> <addr-line>Faculty of Health Sciences, School of Physical Therapy, Western University, London, Canada</addr-line></aff>
<aff id="aff004"><label>4</label> <addr-line>Department of Trauma and Orthopaedics, Young Adult Hip Service, Addenbrooke’s – Cambridge University Hospital NHS Foundation Trust, Cambridge, United Kingdom</addr-line></aff>
<contrib-group>
<contrib contrib-type="editor" xlink:type="simple">
<name name-style="western">
<surname>Zadro</surname>
<given-names>Joshua Robert</given-names>
</name>
<role>Editor</role>
<xref ref-type="aff" rid="edit1"/>
</contrib>
</contrib-group>
<aff id="edit1"><addr-line>The University of Sydney, AUSTRALIA</addr-line></aff>
<author-notes>
<fn fn-type="conflict" id="coi001">
<p>I have read the journal’s policy and the authors of this manuscript have the following competing interests: Dr Khanduja reported being a chief investigator for the NIHR doctoral fellowship during the conduct of the study; receiving consulting fees from Smith &amp; Nephew PLC and Arthrex Inc, outside the submitted work; serving as a board member for the UK Non-Arthroplasty Hip Registry, British Hip Society, European Society of Sports Traumatology, Knee Surgery, and Arthroscopy, and the International Society of Orthopaedic Surgery and Traumatology; and serving on the editorial boards of the Journal of Clinical Orthopaedics and Trauma, International Journal of Orthopaedics, International Orthopaedics, and Open Access Journal of Sports Medicine. This does not alter our adherence to PLOS ONE policies on sharing data and materials. No other disclosures were reported.</p>
</fn>
<corresp id="cor001">* E-mail: <email xlink:type="simple">vk279@cam.ac.uk</email></corresp>
</author-notes>
<pub-date pub-type="epub">
<day>11</day>
<month>4</month>
<year>2024</year>
</pub-date>
<pub-date pub-type="collection">
<year>2024</year>
</pub-date>
<volume>19</volume>
<issue>4</issue>
<elocation-id>e0301194</elocation-id>
<history>
<date date-type="received">
<day>14</day>
<month>9</month>
<year>2023</year>
</date>
<date date-type="accepted">
<day>11</day>
<month>3</month>
<year>2024</year>
</date>
</history>
<permissions>
<copyright-year>2024</copyright-year>
<copyright-holder>Punnoose et al</copyright-holder>
<license xlink:href="http://creativecommons.org/licenses/by/4.0/" xlink:type="simple">
<license-p>This is an open access article distributed under the terms of the <ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0/" xlink:type="simple">Creative Commons Attribution License</ext-link>, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.</license-p>
</license>
</permissions>
<self-uri content-type="pdf" xlink:href="pone.0301194.pdf"/>
<abstract>
<sec id="sec001">
<title>Background</title>
<p>The past decade has seen an exponential growth of minimally invasive surgical procedures. Procedures such as hip arthroscopy have rapidly grown and become the standard of care for patients with Femoroacetabular Impingement Syndrome (FAIS). Although, the results of such procedures are encouraging, a large proportion of patients do not achieve optimal outcomes due to chronicity and deconditioning as a result of delay in diagnosis and increased waiting times amongst other factors. In a recent systematic review and meta-analysis of randomised control trials, moderate certainty evidence supported prehabilitation over standard care in optimising several domains including muscle strength, pain and health related quality of life in patients undergoing orthopaedic surgical interventions. However, the role of prehabilitation in patients with FAI syndrome undergoing hip arthroscopy has received little attention.</p>
</sec>
<sec id="sec002">
<title>Aim</title>
<p>To evaluate the feasibility, suitability, acceptability and safety of a prehabilitation programme for FAI to inform a future definitive randomised control trial to assess effectiveness.</p>
</sec>
<sec id="sec003">
<title>Methods</title>
<p>A systematically developed prehabilitation intervention based on a literature review and international consensus will be utilised in this study. A mixed methodology encompassing a two-arm randomised parallel study alongside an embedded qualitative component will be used to answer the study objectives. Patients will be recruited from a tertiary referral NHS centre for young adult hip pathology in the UK. Patient reported outcomes such as iHOT-12, Brief Pain Inventory Scale (Short form), Hospital Anxiety and Depression Scale and Patient Global Impression of Change score will be obtained alongside objective measurements such as Muscle Strength and Star Excursion Balance Test at various time points. Outcome measures will be obtained at baseline (prior to prehabilitation intervention), after prehabilitation before surgery, and at 6 weeks+/- 4 weeks and 6 months +/- 4 weeks (planned primary endpoint for definitive RCT) postoperatively when participants attend the research site for clinical care and remotely at 12 months +/- 4 weeks postoperatively. Mean change and 95% CI, and effect size of outcome measures will be used to determine the sample size for a future RCT. For the qualitative component, in depth face-to-face semi-structured interviews with physiotherapists and focus groups with participants will be conducted to assess the feasibility, suitability, and acceptability of the prehabilitation intervention using a predetermined success criteria. All qualitative data will be recorded, transcribed verbatim and thematically analysed.</p>
</sec>
<sec id="sec004">
<title>Discussion</title>
<p>This study will be first of its kind to evaluate a systematically developed prehabilitation intervention for patients with FAIS undergoing hip arthroscopy. This study will provide important preliminary data to inform feasibility of a definitive RCT in the future to evaluate effectiveness of a prehabilitation intervention.</p>
</sec>
<sec id="sec005">
<title>Trial registration</title>
<p>ISRCTN <ext-link ext-link-type="uri" xlink:href="https://www.isrctn.com/ISRCTN15371248" xlink:type="simple">15371248</ext-link>, 09/03/2023.</p>
</sec>
<sec id="sec006">
<title>Trial protocol</title>
<p>Version 2.3, 26th June 2023.</p>
</sec>
</abstract>
<funding-group>
<award-group id="award001">
<funding-source>
<institution-wrap>
<institution-id institution-id-type="funder-id">http://dx.doi.org/10.13039/501100007602</institution-id>
<institution>Programme Grants for Applied Research</institution>
</institution-wrap>
</funding-source>
<award-id>NIHR302117</award-id>
<principal-award-recipient>
<contrib-id authenticated="true" contrib-id-type="orcid">https://orcid.org/0000-0003-4477-2822</contrib-id>
<name name-style="western">
<surname>Punnoose</surname>
<given-names>Anuj</given-names>
</name>
</principal-award-recipient>
</award-group>
<funding-statement>Mr Anuj Punnoose has received funding for his PhD Fellowship from the National Institute of Health &amp; Care Research UK (Award NIHR302117). The funders did not and will not have a role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.</funding-statement>
</funding-group>
<counts>
<fig-count count="2"/>
<table-count count="1"/>
<page-count count="21"/>
</counts>
<custom-meta-group>
<custom-meta id="data-availability">
<meta-name>Data Availability</meta-name>
<meta-value>No datasets were generated or analysed during the current study. All relevant data from this study will be made available upon study completion.</meta-value>
</custom-meta>
</custom-meta-group>
</article-meta>
</front>
<body>
<sec id="sec007" sec-type="intro">
<title>Introduction</title>
<p>Femoroacetabular Impingement syndrome (FAIS) is a well-recognised pathological entity and a common cause of hip and groin pain in young adults [<xref ref-type="bibr" rid="pone.0301194.ref001">1</xref>]. The pathology encompasses a morphological abnormality of the femur (Cam) or the acetabulum (Pincer) and can lead to chondro-labral dysfunction and eventually in some cases early onset of osteoarthritis [<xref ref-type="bibr" rid="pone.0301194.ref002">2</xref>]. An epidemiological study on 200 patients aged 16–65 years, representative of the UK population, reported a high prevalence of FAI with 47% (95% CI [42–51]) showing signs of cam morphology [<xref ref-type="bibr" rid="pone.0301194.ref003">3</xref>]. Additionally, deficits in muscle strength and range of motion (ROM) may lead to altered or increased hip joint loads causing detrimental effects [<xref ref-type="bibr" rid="pone.0301194.ref004">4</xref>, <xref ref-type="bibr" rid="pone.0301194.ref005">5</xref>]. Non-surgical management such as physiotherapy could assist in modifying hip joint loads and address the above physical impairments, although, evidence of the effectiveness of such interventions are currently lacking [<xref ref-type="bibr" rid="pone.0301194.ref006">6</xref>, <xref ref-type="bibr" rid="pone.0301194.ref007">7</xref>].</p>
<p>Excision of the impingement lesion (Cam, pincer or mixed) and addressing chondro-labral pathology through surgical procedures like hip arthroscopy may be necessary to provide better medium to long term outcomes [<xref ref-type="bibr" rid="pone.0301194.ref008">8</xref>]. Innovations in diagnosis and surgical technique have resulted in an exponential growth of hip arthroscopy procedures in the past decade [<xref ref-type="bibr" rid="pone.0301194.ref009">9</xref>]. Furthermore, two recent multicentre randomised controlled trials (RCTs) have found significant improvement in outcomes relating to daily activities and quality of life at 8–12 months following hip arthroscopy compared to physiotherapy [<xref ref-type="bibr" rid="pone.0301194.ref010">10</xref>, <xref ref-type="bibr" rid="pone.0301194.ref011">11</xref>]. The mean between group difference in the iHOT-33 scores was 6·8 [95% CI: 1·7–12·0, p = 0.0093] in favour of hip arthroscopy which exceeded the minimum clinically important difference (MCID) of 6.1 [<xref ref-type="bibr" rid="pone.0301194.ref010">10</xref>]. However, results from these trials demonstrate that only half (51%) of participants in the hip arthroscopy group showed significant improvement on the primary outcome measure–iHOT33 which relates to quality of life at 12 months post-op [<xref ref-type="bibr" rid="pone.0301194.ref010">10</xref>]. Another study from the Non Arthroplasty Hip Registry in the UK of over 4900 patients with FAI, showed only 35% of all patients improve or achieve optimal outcome post-operatively [<xref ref-type="bibr" rid="pone.0301194.ref008">8</xref>]. These findings may suggest that factors other than surgery may contribute to their post-operative outcomes.</p>
<p>Several factors have been shown to influence the outcomes after hip arthroscopy. These include, the presence of OA, severe dysplasia, inadequate removal of the impingement lesion, and soft tissue injury sustained during the procedure [<xref ref-type="bibr" rid="pone.0301194.ref002">2</xref>, <xref ref-type="bibr" rid="pone.0301194.ref012">12</xref>, <xref ref-type="bibr" rid="pone.0301194.ref013">13</xref>]. Amongst the non-surgical factors are prolonged waiting times leading to the chronicity and deconditioning of the muscles [<xref ref-type="bibr" rid="pone.0301194.ref014">14</xref>], deficits in muscle strength [<xref ref-type="bibr" rid="pone.0301194.ref015">15</xref>], psychological distress [<xref ref-type="bibr" rid="pone.0301194.ref016">16</xref>] and presence of concomitant pathologies like gluteal tendinopathy [<xref ref-type="bibr" rid="pone.0301194.ref017">17</xref>] and athletic pubalgia [<xref ref-type="bibr" rid="pone.0301194.ref018">18</xref>]. Therefore, early identification and optimisation prior to surgery will be crucial in delivering optimal post-operative outcomes.</p>
<p>Pre-operative rehabilitation intervention or ‘prehabilitation’ is the process of enhancing a patient’s functional capacity prior to surgery in order to improve post-operative outcomes [<xref ref-type="bibr" rid="pone.0301194.ref019">19</xref>]. Prehabilitation interventions have been tested and found to be beneficial across all age groups and various surgical pathways including orthopaedics [<xref ref-type="bibr" rid="pone.0301194.ref020">20</xref>, <xref ref-type="bibr" rid="pone.0301194.ref021">21</xref>]. It is important for interventions included in the prehabilitation programme to be specific to the clinical condition and tailored to patient needs [<xref ref-type="bibr" rid="pone.0301194.ref020">20</xref>]. A person-centred approach, which allows patients to take control of their own outcomes through prehabilitation, places the patient at the core of their peri-operative pathway. This will heighten their motivation to make positive behavioural changes during the pre-operative phase and provide pre, peri and post-operative benefits [<xref ref-type="bibr" rid="pone.0301194.ref022">22</xref>].</p>
<p>Although the effectiveness of prehabilitation has been investigated in a wide variety of orthopaedic conditions, its effectiveness in patients undergoing hip arthroscopy has received little attention. Recently, a small pilot study on patients with FAI (n = 18) favoured prehabilitation over standard care [<xref ref-type="bibr" rid="pone.0301194.ref023">23</xref>]. However, it is not known if benefits are maintained over a longer period and the study demonstrated a high risk of bias (randomisation process, concealment method, baseline differences between groups). Additionally, although participants were recruited from the NHS, the programme was delivered in a private setting and interventions were not developed using a scientifically robust methodology. The study also did not report on adherence to the exercise interventions, an important issue as low levels of adherence can limit the effectiveness of exercise [<xref ref-type="bibr" rid="pone.0301194.ref024">24</xref>]. These findings suggests that there is a need for a well developed study to assess feasibility, suitability, acceptability and safety of a prehabilitation intervention within the NHS setting prior to a definitive trial to evaluate effectiveness.</p>
</sec>
<sec id="sec008">
<title>Aim</title>
<p>To evaluate the feasibility, suitability, acceptability and safety of a prehabilitation programme for patients with FAIS to inform a future definitive randomised controlled trial to assess effectiveness.</p>
</sec>
<sec id="sec009">
<title>Objectives</title>
<p>The objectives of the study and success criteria are detailed in <xref ref-type="table" rid="pone.0301194.t001">Table 1</xref>.</p>
<table-wrap id="pone.0301194.t001" position="float">
<object-id pub-id-type="doi">10.1371/journal.pone.0301194.t001</object-id>
<label>Table 1</label> <caption><title>Study objectives and success criteria.</title></caption>
<alternatives>
<graphic id="pone.0301194.t001g" mimetype="image" position="float" xlink:href="pone.0301194.t001.tif" xlink:type="simple"/>
<table>
<colgroup>
<col align="left" valign="middle"/>
<col align="left" valign="middle"/>
</colgroup>
<tbody>
<tr>
<td align="left" style="background-color:#AEAAAA"><bold>General objectives</bold></td>
<td align="left" style="background-color:#AEAAAA"><bold>Success criteria</bold></td>
</tr>
<tr>
<td align="left" rowspan="2"><bold>Recruitment procedure</bold></td>
<td align="left">Participants were recruited within the time constraints of the local NHS hospital</td>
</tr>
<tr>
<td align="left">Participants report that there were no challenges with the recruitment procedure</td>
</tr>
<tr>
<td align="left" rowspan="2"><bold>Data collection methods</bold></td>
<td align="left">Data completeness of ≥80%</td>
</tr>
<tr>
<td align="left">Patients and assessors reported that there were no challenges with the data collection methods</td>
</tr>
<tr>
<td align="left" rowspan="2"><bold>Follow-up procedures</bold></td>
<td align="left">100% of participants were contacted for follow-up</td>
</tr>
<tr>
<td align="left">≥80% completion of follow-up outcome measures</td>
</tr>
<tr>
<td align="left" style="background-color:#AEAAAA"><bold>Specific objectives</bold></td>
<td align="left" style="background-color:#AEAAAA"><bold>Success criteria</bold></td>
</tr>
<tr>
<td align="left" colspan="2" style="background-color:#E7E6E6"><bold>Feasibility</bold></td>
</tr>
<tr>
<td align="left"><bold>Participant recruitment rates</bold></td>
<td align="justify">The recruitment rate of this study will be considered sufficient if at least 33% of eligible patients are recruited over a period of 18 months.</td>
</tr>
<tr>
<td align="left"><bold>Attrition rate</bold></td>
<td align="left">&lt;30% dropout</td>
</tr>
<tr>
<td align="left"><bold>Usability of Physitrack</bold></td>
<td align="left">Patients and Physiotherapists reported no challenges with the use of Physitrack and telehealth system.</td>
</tr>
<tr>
<td align="left"><bold>Capacity (time and effort) of clinicians to deliver the programme</bold></td>
<td align="left">Physiotherapists report that they had adequate time and resources available to deliver the programme</td>
</tr>
<tr>
<td align="left" rowspan="2"><bold>Treatment fidelity</bold></td>
<td align="left">≥80% completion of the self-reported checklist</td>
</tr>
<tr>
<td align="left">Physiotherapists reports that there were no barriers identified in the use of self-reported checklists.</td>
</tr>
<tr>
<td align="left" colspan="2" style="background-color:#E7E6E6"><bold>Suitability</bold></td>
</tr>
<tr>
<td align="left" rowspan="2"><bold>Outcome measures</bold></td>
<td align="left">Patients and assessor report that the outcome measures were appropriate and self-explanatory</td>
</tr>
<tr>
<td align="left">Data completeness of ≥80%</td>
</tr>
<tr>
<td align="left"><bold>Adherence to the programme</bold></td>
<td align="left">≥70% of the sessions (face to face + home ex monitored by Physitrack)</td>
</tr>
<tr>
<td align="left"><bold>Time required to undertake each stages of the study</bold></td>
<td align="left">Physiotherapists report that they had enough time to complete each stages of the study.</td>
</tr>
<tr>
<td align="left"><bold>Service infrastructure</bold></td>
<td align="left">Recruitment targets met<break/>Data completeness of ≥80%<break/>Clinicians and researchers report that there was adequate infrastructure to allow completion of a full trial.</td>
</tr>
<tr>
<td align="left" colspan="2" style="background-color:#E7E6E6"><bold>Acceptability</bold></td>
</tr>
<tr>
<td align="left"><bold>Intervention</bold></td>
<td align="left">Patients and clinicians report that the programme was appropriate and satisfactory</td>
</tr>
<tr>
<td align="left"><bold>Randomisation</bold></td>
<td align="left">Patients are willing to be randomised for a future definitive trial.<break/>(≥80%)</td>
</tr>
<tr>
<td align="left" colspan="2" style="background-color:#D9D9D9"><bold>Safety</bold></td>
</tr>
<tr>
<td align="left"><bold>Intervention</bold></td>
<td align="left">Patients report that the intervention was safe, and no serious adverse events occurred during the prehabilitation phase.</td>
</tr>
</tbody>
</table>
</alternatives>
</table-wrap>
<sec id="sec010">
<title>General objectives</title>
<p>To assess the feasibility, suitability, acceptability and safety of a prehabilitation intervention evaluating:</p>
<list list-type="bullet">
<list-item><p>Recruitment procedures</p></list-item>
<list-item><p>Data collection methods</p></list-item>
<list-item><p>Follow-up procedures</p></list-item>
<list-item><p>Determine sample size for a full trial to test its effectiveness</p></list-item>
</list>
</sec>
<sec id="sec011">
<title>Specific objectives</title>
<sec id="sec012">
<title>Feasibility</title>
<list list-type="bullet">
<list-item><p>To evaluate recruitment procedures such as participant recruitment and attrition rates [<xref ref-type="bibr" rid="pone.0301194.ref025">25</xref>]</p></list-item>
<list-item><p>To evaluate follow-up rates and response rates to questionnaires [<xref ref-type="bibr" rid="pone.0301194.ref025">25</xref>]</p></list-item>
<list-item><p>To evaluate the ease of using the Physitrack app [<xref ref-type="bibr" rid="pone.0301194.ref026">26</xref>]</p></list-item>
<list-item><p>To evaluate the time and effort required by clinicians to deliver the intervention [<xref ref-type="bibr" rid="pone.0301194.ref025">25</xref>]</p></list-item>
<list-item><p>To evaluate fidelity of intervention delivery [<xref ref-type="bibr" rid="pone.0301194.ref027">27</xref>]</p></list-item>
</list>
</sec>
<sec id="sec013">
<title>Suitability</title>
<list list-type="bullet">
<list-item><p>To evaluate suitability of the outcome measures [<xref ref-type="bibr" rid="pone.0301194.ref028">28</xref>]</p></list-item>
<list-item><p>To evaluate participant adherence with prehabilitation interventions [<xref ref-type="bibr" rid="pone.0301194.ref025">25</xref>]</p></list-item>
<list-item><p>To evaluate the time taken to undertake each phases of the study [<xref ref-type="bibr" rid="pone.0301194.ref025">25</xref>]</p></list-item>
<list-item><p>To evaluate the appropriateness of incorporating a prehabilitation intervention for FAI into the current NHS services infrastructure [<xref ref-type="bibr" rid="pone.0301194.ref029">29</xref>]</p></list-item>
</list>
</sec>
<sec id="sec014">
<title>Acceptability</title>
<list list-type="bullet">
<list-item><p>To evaluate the acceptability of interventions to patients and clinicians [<xref ref-type="bibr" rid="pone.0301194.ref028">28</xref>]</p></list-item>
<list-item><p>To evaluate the willingness of patients to participate in a full RCT in the future [<xref ref-type="bibr" rid="pone.0301194.ref028">28</xref>]</p></list-item>
</list>
</sec>
<sec id="sec015">
<title>Safety</title>
<list list-type="bullet">
<list-item><p>To evaluate the safety of the intervention [<xref ref-type="bibr" rid="pone.0301194.ref025">25</xref>]</p></list-item>
</list>
</sec>
</sec>
</sec>
<sec id="sec016" sec-type="materials|methods">
<title>Methods</title>
<p>This feasibility study protocol will be reported as per the CONSORT 2010 statement: extension to randomised pilot and feasibility trials to ensure transparency and reproducibility [<xref ref-type="bibr" rid="pone.0301194.ref030">30</xref>] and has been registered on the ISRCTN database. This study has received ethics approval from East of England—Cambridge Central Research Ethics Committee (IRAS ID: 293927, REC Ref 23/EE/0024 dated 01/02/2023) and began recruitment from the 21<sup>st</sup> of April 2023. Further amendments (SA 01, dated 10/2/2023; SA 02, dated 20/04/23, SA 03, dated 28/06/23) to the protocol are specified below. The Sponsor and Ethics committee will be informed of any future changes to the protocol and the Trial registry will be updated accordingly.</p>
</sec>
<sec id="sec017">
<title>Protocol amendments</title>
<list list-type="order">
<list-item><p>Study follow-up points will be +/- 4 weeks to accommodate flexibility in clinic appointment within the NHS. Upon further consideration of the current situation and waiting times within the NHS, having a rigid follow-up point would not be feasible. Therefore, the follow-up points are kept flexible, but within a reasonable duration, so this does not affect the quality of the study.</p></list-item>
<list-item><p>Patient reported outcome measures will be completed digitally via online surverys at baseline and all other follow-up points (at pre-op, 6 weeks,6 months and 12 months post-op) using REDCap. Participants will receive an email containing a link to the online outcome measure survey along with instructions for completion during the specified follow-up intervals mentioned above. If participants forget to complete the outcome questionnaire on the required day, a reminder to complete it will be sent on two more occasions after the deadline to facilitate compliance.</p></list-item>
<list-item><p>The REDCap database will be used to collect and store the data for the study and will therefore be more secure and will strictly follow all UK and GDPR guidelines.</p></list-item>
<list-item><p>Both PI and Chief Investigator are part of the direct clinical team and routinely collect and review data regarding patient demographics, clinical examination details and details of any investigations done for their care. The above details will be collected and utilised for the purpose of the study. This information is mentioned on the current PIS, however not explicitly and covering all the above terms mentioned. This will be stored securely in the hospital computers and REDCap database as mentioned above. If a need arises to share data or present at meetings for dissemination, this data will be anonymised, and no patient identifiable details will be presented.</p></list-item>
<list-item><p>Following baseline evaluation, participants will be randomly allocated to one of the two groups (prehabilitation or usual care) by the PI using a computer-generated simple random allocation sequence. This will be uploaded to REDCap and all study personnel will be blinded to the allocation sequence ensuring adequate concealment.</p></list-item>
<list-item><p>Pre-op education session will be delivered virtually via Zoom/MS Teams. This is to reduce the impact on patient travel and reduce the need for additional resources e.g room availability in the hospital</p></list-item>
<list-item><p>Two or more focus group (8–10 participants) will be conducted as needed. This is to improve data quality and may achieve data saturation in a robust manner improving the overall quality of the study. This will only be implemented with participant’s explicit consent.</p></list-item>
</list>
</sec>
<sec id="sec018">
<title>Design</title>
<p>A randomised controlled study design (RCT) is considered as gold standard when evaluating the effectiveness of an intervention as it eliminates various biases prevalent in other study designs [<xref ref-type="bibr" rid="pone.0301194.ref031">31</xref>]. However, a RCT can be challenging with several unknown factors at play (recruitment, adherence, attrition, acceptability and suitability of interventions). Therefore, prior to evaluating the effectiveness of an intervention, researchers are encouraged to assess its feasibility, suitability, acceptability, and safety, and optimise the overall design of the trial to ensure any uncertainties are addressed prior to a full trial [<xref ref-type="bibr" rid="pone.0301194.ref027">27</xref>, <xref ref-type="bibr" rid="pone.0301194.ref032">32</xref>].</p>
<p>This feasibility trial will use a mixed methodology encompassing the following;</p>
<list list-type="bullet">
<list-item><p>A quantitative two arm parallel group feasibility trial</p></list-item>
<list-item><p>An embedded qualitative component consisting of semi-structured interviews with physiotherapists and patient focus groups using thematic analysis</p></list-item>
</list>
<sec id="sec019">
<title>Quantitative component of study</title>
<p>It is imperative that steps are undertaken to improve the methodological rigour right at the initial stages of any research study [<xref ref-type="bibr" rid="pone.0301194.ref033">33</xref>]. Consistent with the Medical Research Council Framework recommendations for developing and evaluating complex interventions [<xref ref-type="bibr" rid="pone.0301194.ref032">32</xref>], it is crucial to develop the intervention prior to testing its efficacy or effectiveness. A recent systematic review and meta-analysis conducted by the lead authors Punnoose &amp; Claydon-Mueller et al., analysed 48 unique trials investigating the effectiveness of prehabilitation in patients undergoing orthopaedic surgery [<xref ref-type="bibr" rid="pone.0301194.ref021">21</xref>]. This study included both published and unpublished trials until June 2022 and synthesised evidence on the effectiveness of prehabilitation on several outcome domains including quality of life, pain, muscle strength and function, laying a thorough foundation to the prehabilitation intervention used in this study. Alongside underscoring the effectiveness of prehabilitation, the study also reported on the optimum duration, dosage and frequency of prehabilitation, and emphasised on the importance of reporting adherence to the exercise intervention. However, majority of studies (85%, n = 41) included in the systematic review were on joint replacements, highlighting the lack of good quality research around prehabilitation effectiveness in other orthopaedic surgical procedures such as Anterior cruciate ligament reconstruction and FAIS.</p>
<p>Due to the lacunae of literature around prehabilitation components and its parameters within the FAIS population, an expert panel consensus statement with 17 international experts defined the core components of the intervention [<xref ref-type="bibr" rid="pone.0301194.ref034">34</xref>]. The study recommended 6 core domains to be targeted during the pre-operative phase- muscle strength, range of motion, proprioception,cardiovascular fitness, anxiety and depression and addressing any co-existing pathologies alongside FAIS. Additionally, the consensus statement recommended that prehabilitation for FAIS be delivered for 6–8 weeks as a combination of face to face and virtually via telehealth. This study is currently in its preparatory stages of publication. The resulting prehabilitation intervention developed though this rigorous process are detailed in <xref ref-type="supplementary-material" rid="pone.0301194.s001">S1 Appendix</xref>.</p>
<p>A prospective mixed methods, two group parallel feasibility study will be conducted to answer the above objectives [<xref ref-type="bibr" rid="pone.0301194.ref028">28</xref>]. <xref ref-type="fig" rid="pone.0301194.g001">Fig 1</xref> shows the schedule of enrolment, interventions, and assessments for the study. Objective outcome measures will be obtained at baseline (prior to prehabilitation intervention), after prehabilitation before surgery, and at 6 weeks+/- 4 weeks and 6 months+/- 4 weeks (planned primary endpoint for definitive RCT) postoperatively when participants attend the research site for clinical care. Additionally, all patient reported outcome measures will be captured at 12 months+/-4 weeks post-op. Physical outcome measures will be assessed onsite during the participant’s clinical visits and patient reported outcomes will be collected digitally via REDCap (Research Electronic Data Capture) [<xref ref-type="bibr" rid="pone.0301194.ref035">35</xref>, <xref ref-type="bibr" rid="pone.0301194.ref036">36</xref>] (see <xref ref-type="fig" rid="pone.0301194.g002">Fig 2</xref>). The online outcome measure survey will be built using REDCap enabling real time data to be captured and stored securely. Participants will receive an email containing a link to the online outcome measure survey along with instructions for completion during the specified follow-up intervals mentioned above. If incomplete, two additional reminders will be sent to the participants after the deadline to facilitate compliance.</p>
<fig id="pone.0301194.g001" position="float">
<object-id pub-id-type="doi">10.1371/journal.pone.0301194.g001</object-id>
<label>Fig 1</label>
<caption>
<title>Schedule of enrolment, interventions, and assessments.</title>
</caption>
<graphic mimetype="image" position="float" xlink:href="pone.0301194.g001.tif" xlink:type="simple"/>
</fig>
<fig id="pone.0301194.g002" position="float">
<object-id pub-id-type="doi">10.1371/journal.pone.0301194.g002</object-id>
<label>Fig 2</label>
<caption>
<title>Timeline for interventions and outcome measures.</title>
</caption>
<graphic mimetype="image" position="float" xlink:href="pone.0301194.g002.tif" xlink:type="simple"/>
</fig>
<sec id="sec020">
<title>Participants</title>
<p>The study will be conducted at a single tertiary Young Adult Hip Service at a National Health Service (NHS) hospital. Potential participants will be identified from the waiting list for hip arthroscopy at the NHS site. This will be performed by the Chief Investigator or the Principal Investigator (PI) who is a part of the direct clinical care team. Potential participants for the study will be contacted if their surgical date in the future will allow appropriate time for the consent process, randomisation and 8 weeks of prehabilitation intervention.</p>
<p>A Patient Information Sheet (PIS) will be provided to participants to facilitate the consenting process. The research team will ensure that they adequately explain the aim, study treatment, potential benefits or harm of taking part in the trial to the participants. They will also re-iterate that participation is voluntary and participants can withdraw from the study at any time, without giving a reason. Participants will be phoned after 1 week from when they have received the PIS to see if they are interested in taking part. For patients interested in participating, written consent to participate in the study will be confirmed at first face to face contact during their routine pre-op assessment. If this is not possible due to any reason, the consent process will be completed over the phone. The consent process will be witnessed by a member of staff independent of the trial team. The PI (or delegate) will sign the consent form as the person receiving consent and the independent witness will sign the consent form to confirm that the consent process was followed and the participant gave their verbal consent to take part. Participants will be asked to sign the consent form when they come for their surgery. A copy of the consent form will be given to them at this point. Participants will be provided with the current version of the REC approved patient information sheet to read. Participants will have the opportunity to pose any questions, and consent will be obtained by the Principal Investigator or a qualified member of the clinical care team only after addressing all of their inquiries. Participants can withdraw their consent at any point during the study. This will be recorded in their electronic patient records. A sample of the consent form can be found in <xref ref-type="supplementary-material" rid="pone.0301194.s002">S2 Appendix</xref></p>
</sec>
</sec>
<sec id="sec021">
<title>Eligibility criteria</title>
<sec id="sec022">
<title>Inclusion criteria</title>
<p>All patients referred to Cambridge Young Adult Hip Service (aged 16–50 years), undergoing hip arthroscopy for the management of FAIS.</p>
</sec>
<sec id="sec023">
<title>Exclusion criteria</title>
<list list-type="bullet">
<list-item><p>Previous hip disease such as Perthe’s, Slipped upper femoral epiphysis or avascular necrosis [<xref ref-type="bibr" rid="pone.0301194.ref010">10</xref>]</p></list-item>
<list-item><p>Participants who are unable to give full written consent</p></list-item>
<list-item><p>Participants who are not fluent in English</p></list-item>
<list-item><p>Pre-existing neuromuscular conditions like Motor Neuron Disease or Multiple Sclerosis</p></list-item>
<list-item><p>History of any previous hip surgery</p></list-item>
<list-item><p>History of any previous hip arthroscopies</p></list-item>
</list>
</sec>
</sec>
<sec id="sec024">
<title>Interventions</title>
<p>All participants, regardless of group allocation, will receive standard peri &amp; post-operative care and rehabilitation. A record of their analgesia consumption will be noted during their follow-up appointments (pre-op, post-op 6 weeks and 6 months) in a logbook built in REDCap by a member of the research team.</p>
<sec id="sec025">
<title>Prehabilitation intervention</title>
<p>Interventions are described based on the Template for Intervention Description and Replication (TIDieR) to allow reproducibility [<xref ref-type="bibr" rid="pone.0301194.ref037">37</xref>]. The intervention will be delivered over a period of 8 weeks prior to surgery and will target 5 domains- muscle strength, range of motion, proprioception, cardiovascular fitness and addressing co-existing pathologies. Literature suggests high prevalence and poorer outcomes of depression and anxiety in people with FAI [<xref ref-type="bibr" rid="pone.0301194.ref016">16</xref>, <xref ref-type="bibr" rid="pone.0301194.ref038">38</xref>], and the intervention will therefore also include an educational session delivered virtually via Microsoft Teams software by the PI to provide greater understanding of the surgery to alleviate anxiety and help manage patient expectations. The intervention will include at least four in-clinic face-to-face sessions (once a fortnight) with an experienced physiotherapist (&gt;2 years’ experience in treating musculoskeletal conditions including FAIS) followed by upto six to eight remotely monitored sessions (once a week) using a telehealth system (<xref ref-type="fig" rid="pone.0301194.g002">Fig 2</xref>). The number of sessions will be determined based on physiotherapist assessment and intensity and complexity of exercises will be gradually increased depending on each participant’s individual progress. Due to the wide variation of patient characteristics within the FAIS population (e.g. sedentary or athletic) interventions will be tailored according to individual participant’s capabilities assessed by their treating physiotherapist. Components of the prehabilitation interventions are designed not to aggravate patient symptoms. However, in case of worsening of symptoms, the physiotherapist will re-evaluate and adapt the exercises to ensure safety. Details of the prehabilitation intervention is described in <xref ref-type="supplementary-material" rid="pone.0301194.s001">S1 Appendix</xref>.</p>
<p>Physitrack provides exercise information and videos via website and apps. Dosage and frequency of the exercises can be selected, and patients will be encouraged to record completion of the exercises enabling the physiotherapist to measure adherence via the app. Physitrack has been found to improve adherence and patient confidence and is utilised across several NHS Trusts in the UK [<xref ref-type="bibr" rid="pone.0301194.ref039">39</xref>]. Additionally, the use of Physitrack’s tele-rehabilitation would enable physiotherapists and patients to interact with each other via video providing reassurance of the correct exercise techniques and progression [<xref ref-type="bibr" rid="pone.0301194.ref040">40</xref>].</p>
<p>The participants in the intervention group will use Physitrack which provides photos and videos of the prescribed exercises and those unable to use the app will be provided with paper-based instructions. Additionally, patients will be asked to complete their exercises at home twice weekly.</p>
<p>The prehabilitation intervention will be delivered by experienced physiotherapists as described above. All the rehabilitation components are standard clinical therapies familiar to a trained physiotherapist. The physiotherapists will undergo training (by PI) on how to deliver these components together as per the protocol for this study. A representative from Physitrack will be invited to deliver training on the use of the app.</p>
</sec>
<sec id="sec026">
<title>Usual care intervention</title>
<p>As per the host hospital’s current clinical guidelines, the usual care intervention consists of advice to continue with normal activities and no prehabilitation therapy.</p>
</sec>
</sec>
<sec id="sec027">
<title>Randomisation and blinding</title>
<p>A simple random allocation sequence will be generated using GraphPad QuickCalcs website [<xref ref-type="bibr" rid="pone.0301194.ref041">41</xref>] and uploaded to REDCap. Once patients are allocated to one of the two groups (prehabilitation or standard care), all baseline data will be obtained. All study personnel will be blinded to the allocation sequence ensuring adequate concealment [<xref ref-type="bibr" rid="pone.0301194.ref035">35</xref>, <xref ref-type="bibr" rid="pone.0301194.ref036">36</xref>].</p>
<p>Blinding participants and clinicians delivering interventions will not be possible as both will be aware of the intervention and allocation. However, the content of the programme will only be known to participants in the intervention group thereby reducing the risk of cross contamination between groups [<xref ref-type="bibr" rid="pone.0301194.ref042">42</xref>]. Physical outcome measures will be measured by a blinded assessor who will be trained by the PI to ensure standardisation and improve reliability of the assessment.</p>
</sec>
<sec id="sec028">
<title>Outcome measures</title>
<p>All physical and patient reported outcome measures will be collected at various time points as explained above and in Figs <xref ref-type="fig" rid="pone.0301194.g001">1</xref> and <xref ref-type="fig" rid="pone.0301194.g002">2</xref>.</p>
<sec id="sec029">
<title>Primary clinical outcome measure</title>
<p><italic>iHOT-12</italic>. The iHOT-12 is a patient reported outcome of Quality of Life (QoL) [<xref ref-type="bibr" rid="pone.0301194.ref043">43</xref>] and will be the planned primary outcome measure for this study. This shorter version of the original iHOT-33 was developed and validated for patients with FAIS and was found to be valid, responsive and a reliable tool to measure the impact of hip disease in young active individuals on QoL [<xref ref-type="bibr" rid="pone.0301194.ref043">43</xref>].The minimal clinical important difference for the iHOT-12 is 13.0 and patient acceptable symptom state threshold is 63.0 for FAIS [<xref ref-type="bibr" rid="pone.0301194.ref044">44</xref>].</p>
</sec>
<sec id="sec030">
<title>Secondary clinical outcome measures</title>
<p><italic>Muscle strength using handheld dynamometer</italic>. Several studies have discussed the implications of reduced muscle strength in the hip and how this could predispose to lower extremity injuries [<xref ref-type="bibr" rid="pone.0301194.ref045">45</xref>–<xref ref-type="bibr" rid="pone.0301194.ref047">47</xref>]. A recent systematic review evaluating muscle strength measurement in various hip pathologies reported that there is evidence of bilateral hip muscle weakness regardless of whether the hip joint is symptomatic or not [<xref ref-type="bibr" rid="pone.0301194.ref048">48</xref>]. Both motor driven and hand-held dynamometry (HHD) are reliable methods of muscle strength measurement and should be used with make tests (where the patient pushes against the examiner’s fixed resistance) [<xref ref-type="bibr" rid="pone.0301194.ref048">48</xref>]. For ease of use in a clincal setting, a HHD will be used in this study. HHD with an external belt fixation has shown good inter-tester reliability with intra-class coefficient of 2.1 (range 0.76 to 0.95) [<xref ref-type="bibr" rid="pone.0301194.ref049">49</xref>]. Maximum voluntary isometric contraction will be utilised as the measurement for all hip muscles groups [<xref ref-type="bibr" rid="pone.0301194.ref050">50</xref>]. A minimum detectable change (MDC) score is often used to detect real change in an outcome measure overtime [<xref ref-type="bibr" rid="pone.0301194.ref051">51</xref>]. An MDC value at 95% CI ranging from 9–45 points was reported for individual hip muscle groups in healthy subjects using a HHD showing it is responsiveness [<xref ref-type="bibr" rid="pone.0301194.ref052">52</xref>]. Further details on how to perform the tests are described in <xref ref-type="supplementary-material" rid="pone.0301194.s003">S3 Appendix</xref>.</p>
<p><italic>Star Excursion Balance Test (SEBT)</italic>. The SEBT is a reliable measure to assess dynamic postural control and proprioception and has shown excellent inter-rater reliability [<xref ref-type="bibr" rid="pone.0301194.ref053">53</xref>]. The SEBT has shown good criterion and divergent validity in relation to pain, hip strength and ROM in patients with FAI [<xref ref-type="bibr" rid="pone.0301194.ref054">54</xref>, <xref ref-type="bibr" rid="pone.0301194.ref055">55</xref>]. See <xref ref-type="supplementary-material" rid="pone.0301194.s003">S3 Appendix</xref>.</p>
<p><italic>Brief Pain Inventory-short form (BPI)</italic>. Most patients with FAI experience pain in the hip or groin [<xref ref-type="bibr" rid="pone.0301194.ref056">56</xref>], often chronic in nature. BPI is a multidimensional scale that can reliably measure chronic pain and its interference with an individual’s physical and social functioning [<xref ref-type="bibr" rid="pone.0301194.ref057">57</xref>]. The tool is responsive to change in pain associated with pharmacological, physical as well as psychological interventions and was recommended by the Initiative on Methods, Measurement, and Pain Assessment in Clinical Trials [<xref ref-type="bibr" rid="pone.0301194.ref058">58</xref>].</p>
<p><italic>Hospital Anxiety and Depression Scale (HADS)</italic>. Recent studies have shown the prevalence of anxiety and depression in patients undergoing hip arthroscopic procedures [<xref ref-type="bibr" rid="pone.0301194.ref016">16</xref>, <xref ref-type="bibr" rid="pone.0301194.ref038">38</xref>]. Previous studies have reported improvements in the level of anxiety and depression experienced by patients when undergoing prehabilitation [<xref ref-type="bibr" rid="pone.0301194.ref059">59</xref>, <xref ref-type="bibr" rid="pone.0301194.ref060">60</xref>]. The HADS scale is a validated tool to measure anxiety and depression in general medical population of patients and will be utilised in the study [<xref ref-type="bibr" rid="pone.0301194.ref061">61</xref>]. A literature review including 747 papers reported a sensitivity and specificity of 0.8 at a cut off score of &gt;8 on HADS which was very similar to other health questionnaires [<xref ref-type="bibr" rid="pone.0301194.ref062">62</xref>].</p>
<p><italic>Patient’s Global Impression of change (PGIC)</italic>. The Global rating of change (GRC) scales are often used in research particularly within the musculoskeletal area [<xref ref-type="bibr" rid="pone.0301194.ref063">63</xref>]. Among the GRC scales, PGIC scale is frequently used to gather a patient’s perception of change after an intervention. The scale typically consists of 7 points which depicts a patient’s overall improvement from “very much improved” to “very much worse [<xref ref-type="bibr" rid="pone.0301194.ref064">64</xref>]. These scales have shown adequate reproducibility and sensitivity to change in a variety of disorders, and are easy to use and interpret [<xref ref-type="bibr" rid="pone.0301194.ref063">63</xref>].</p>
</sec>
</sec>
<sec id="sec031">
<title>Participant demographic data</title>
<p>Participant baseline demographic data including age, gender, height, weight, Body Mass Index, duration of symptoms and work status will be recorded on REDCap once they have consented to participate in the study. Additionally, details of their physical examination, investigations and past medical history recorded as a part of their routine care will be collected and used for the purpose of this study.</p>
</sec>
<sec id="sec032">
<title>Sample size</title>
<p>An overall sample size of 24–50 is recommended to estimate the standard deviations for calculating sample size required for a full trial [<xref ref-type="bibr" rid="pone.0301194.ref065">65</xref>–<xref ref-type="bibr" rid="pone.0301194.ref067">67</xref>]. As this is a feasibility study, the sample size will be based on recruitment rate over a period of 18 months. As a tertiary referral centre for hip arthroscopy, we anticipate around 48 eligible patients over a period of 18 months. We could estimate a recruitment rate of 33% (i.e. 16 participants) to take part in the study within a 95% confidence interval of ±10.5%.</p>
</sec>
<sec id="sec033">
<title>Data analysis</title>
<p>A CONSORT diagram will be used to describe and analyse recruitment and attrition rates [<xref ref-type="bibr" rid="pone.0301194.ref030">30</xref>]. Data will be analysed using SPSS version 28. Between group baseline demographic data will be analysed using independent t-tests for continuous variables and chi-square tests for categorical variables. Descriptive statistics, such as percentages (for rate calculations), means, standard deviations and mean change (if data are normally distributed) will be analysed to evaluate distribution of scores and analyse the floor and ceiling effect of the primary outcome measure. Floor and ceiling effects are defined the percentage of participants who scored the minimum (floor) and maximum (ceiling) possible score in an outcome measure [<xref ref-type="bibr" rid="pone.0301194.ref068">68</xref>].</p>
<p>Data will be reported using Intention to treat analysis [<xref ref-type="bibr" rid="pone.0301194.ref069">69</xref>]. Standard deviations and effect sizes for the primary outcome measure will be used to calculate the required sample size for a definitive trial in the future.</p>
<p>This is a feasibility trial of exercise interventions and will carry minimal risks. Therefore, a formal data monitoring committee is not required.</p>
</sec>
</sec>
<sec id="sec034">
<title>Qualitative component of study</title>
<sec id="sec035">
<title>Design</title>
<p>An embedded qualitative component will be utilised to answer specific trial objectives and to refine and adapt the design prior to the full RCT. Prior to participating in the qualitative study, participants will be provided with an information leaflet and opportunity will be given to raise any questions to the researchers regarding the processes. Consent from all participants will be obtained prior to taking part in the interviews and focus groups.</p>
</sec>
<sec id="sec036">
<title>Physiotherapist participants</title>
<p>In-depth face to face semi structured interviews will be used to explore the views of the physiotherapists (n = 4) regarding the feasibility, suitability and acceptability of the intervention, outcome measures as well as the Physitrack app in an NHS setting as described below. Physiotherapists involved in the delivery of the interventions and collection of outcome measures will be invited for this purpose. The interviews will be conducted by the PI within one year of commencement of the study. Appropriate questions for the interviews will be developed by the PI and the supervisory team prior to conducting the interviews. A patient and public involvement group will review the questions for clarity and appropriateness [<xref ref-type="bibr" rid="pone.0301194.ref070">70</xref>].</p>
</sec>
<sec id="sec037">
<title>Research participants</title>
<p>Two or more focus groups with research participants will be conducted until data saturation has been achieved following the 6 months assessment point to evaluate the research objectives. A purposive sample of 8–10 participants based on characteristics such as group allocation, adherence and time in their clinical pathway (pre-op &amp; post-op) will be included as recommended in the literature [<xref ref-type="bibr" rid="pone.0301194.ref071">71</xref>]. A predetermined topic guide developed by the PI and reviewed by the PPI panel will be used for the focus group. The focus groups will be conducted by 2 researchers: the PI (facilitator) and a supervisor (observer).</p>
</sec>
<sec id="sec038">
<title>Data analysis</title>
<p>All qualitative data will be recorded and transcribed verbatim. The personal assistant to the Chief investigator (VK) will be responsible for the transcriptions. As a member of staff, they will follow all guidelines of confidentiality and information governance procedures as per the host hospital’s policy. Once used, all original recordings will be deleted. Quality of the data will be ensured via practitioner and assessor training, data completeness and accuracy.</p>
<p>All transcribed qualitative data will be thematically analysed [<xref ref-type="bibr" rid="pone.0301194.ref072">72</xref>]. It is anticipated that the qualitative data captured will have a diverse range of opinions due to the novel nature of the intervention and an inductive approach will be best suited for this purpose [<xref ref-type="bibr" rid="pone.0301194.ref072">72</xref>]. Transcripts will be reviewed by the participants for credibility [<xref ref-type="bibr" rid="pone.0301194.ref073">73</xref>] prior to analysis by the researchers using Nvivo 14 software [<xref ref-type="bibr" rid="pone.0301194.ref074">74</xref>]. For credibility and confirmability of the qualitative data, coding and themes will be analysed by the PI and re-checked by the primary academic supervisor (LCM).</p>
</sec>
</sec>
<sec id="sec039">
<title>Feasibility, suitability, acceptability and safety of the intervention</title>
<p>A pre-determined success criteria will be used to analyse the quantitate and qualitative data (<xref ref-type="table" rid="pone.0301194.t001">Table 1</xref>). The study objectives will be considered successful if the success criteria were satisfied upon integration of data derived from both quantitative and qualitative methods.</p>
<sec id="sec040">
<title>Feasibility measures</title>
<p>Feasibility parameters will be utilised to answer the objectives as per <xref ref-type="table" rid="pone.0301194.t001">Table 1</xref>. The recruitment rate will be determined by the number of participants who are eligible and consent to participate in the study. Attrition will be defined by the number of consenting participants who drop out during the study. Timing of dropouts and reasons (where provided) will be explored to determine if the follow-up points are appropriate prior to a definitive RCT. Follow-up rates and response rates to questionnaires will be collected at each follow-up point. The usability of the Physitrack app and tele-rehabilitation will be evaluated using a modified System Usability Scale (SUS) [<xref ref-type="bibr" rid="pone.0301194.ref026">26</xref>]. Time and effort of clinicians delivering the interventions will be captured via the hospital’s electronic system.</p>
<p>Treatment fidelity is the extent to which an intervention is delivered as per study protocol and is critical in the development and testing of evidence-based interventions [<xref ref-type="bibr" rid="pone.0301194.ref075">75</xref>]. Assessing fidelity in the feasibility stage is also critical to identify interventions that have lower than expected fidelity which can then be used to refine interventions prior to a full trial [<xref ref-type="bibr" rid="pone.0301194.ref076">76</xref>]. Fidelity will be monitored by analysing self-reported checklists completed by the treating Physiotherapists. A numerical rating scale (5 point Likert scale) will be used to measure content and quality of the interventions and post-session feedback will be given to the clinicians to improve treatment delivery [<xref ref-type="bibr" rid="pone.0301194.ref077">77</xref>].</p>
</sec>
<sec id="sec041">
<title>Suitability measures</title>
<p>Physiotherapists and participants will be asked the appropriateness of outcome measures as well as time and effort required to complete them. Adherence to the intervention will be measured by capturing the number of exercises sessions delivered face-to-face and home exercises remotely monitored by Physitrack app. Qualitative data from the interviews and the focus group will also be collected to develop a training manual and to establish if there is adequate resources and infrastructure at the host hospital to support a definitive trial in the future.</p>
</sec>
<sec id="sec042">
<title>Acceptability measures</title>
<p>Acceptability of the interventions will be evaluated during focus groups with participants using qualitative methods.</p>
</sec>
<sec id="sec043">
<title>Safety measures</title>
<p>Safety of the interventions will be determined based on the number and nature of adverse events. All adverse events (related or unrelated to interventions) will be recorded. Components of the prehabilitation interventions are designed not to aggravate patient symptoms. However, in case of worsening of symptoms, the physiotherapist will re-evaluate and adapt the exercises to ensure safety.</p>
</sec>
<sec id="sec044">
<title>Data storage</title>
<p>Data collected will be stored safely on REDCap database which can be accessed only by the study investigators at the host institution. Additionally, personal data of participants will be stored securely on EDGE- a clinical research management platform approved by the host institution and will follow GDPR (General Data Protection Regulations) guidelines [<xref ref-type="bibr" rid="pone.0301194.ref078">78</xref>]. Monitoring and auditing of the data by the sponsor hospital’s R&amp; D might be required during the study, however, all patent identifiable data will be removed prior to sharing the data. All personal data used for the study will be destroyed at the end of the study. Pseudo-anonymised quotations from the respondents might be used for dissemination such as peer reviewed publications or conferences. No single patient data will be reported or published ensuring confidentiality.</p>
</sec>
</sec>
<sec id="sec045">
<title>Data availability</title>
<p>No datasets were generated or analysed during the current study. All relevant data from this study will be made available upon study completion.</p>
</sec>
<sec id="sec046">
<title>End of the study</title>
<p>The end of the study will be declared when the last participant in the study has completed their 1-year post-op follow-up.</p>
</sec>
<sec id="sec047">
<title>Ethics and dissemination</title>
<p>This study raises no major ethical or legal issues. The randomised study design will provide equal opportunities for all participants to treatment allocation. Each participant in the study will be given an opportunity to read and understand the study prior to signing the consent form and they will have the right to withdraw from the study at any time. The intervention will be delivered as a combination of face-to-face and remotely using an app giving equal opportunities for patients who are unable to travel often. Reimbursements for their travel has been included and approved by the funding organisation.</p>
<p>Additionally, participation in the study will not alter their clinical pathway. Outcome measures will be taken at the time of their normal clinical visits reducing their visits to the hospital.</p>
<p>The results of this study will be disseminated to improve awareness and engagement of all parties (patients, research community and the public) in preparation for the future trial. The study results will be shared with the research and scientific community via peer-reviewed publications, open access repositories and scientific meetings and conferences.</p>
</sec>
<sec id="sec048">
<title>Patient and Public Involvement (PPI)</title>
<p>A focus group involving a patient and public panel informed the design of the study. An advisory group will be formed with two people from the PPI panel who will oversee the study. Several activities are planned with the PPI panel during the study as below;</p>
<list list-type="order">
<list-item><p>Co-design the prehabilitation leaflet</p></list-item>
<list-item><p>Develop question guides for the research focus groups and semi structured interviews</p></list-item>
<list-item><p>Co-develop a training manual for clinicians</p></list-item>
<list-item><p>Design dissemination materials</p></list-item>
</list>
<p>All patient and public involvement meetings will be evaluated using an Impact log and reported in line with the GRIPP2 short form reporting checklist [<xref ref-type="bibr" rid="pone.0301194.ref079">79</xref>].</p>
</sec>
<sec id="sec049">
<title>Strengths of the study</title>
<p>To our knowledge, this is the first study to test the feasibility, suitability, acceptability and safety of a newly developed prehabilitation intervention in patients undergoing hip arthroscopy for FAIS. The prehabilitation intervention was developed using a robust methodology underpinned by a systematic review and meta-analysis of the current literature and an international consensus statement. The randomised design and assessor blinding approach will minimise selection, detection, and performance biases. A well-designed prehabilitation study will positively impact patient outcomes by improving strength and function and reduce anxiety prior to surgery thereby ensuring quicker recovery post-op. It is anticipated to reduce socio-economic burden by facilitating continuation or resumption of work and may reduce economic impact on services post-op (e.g., reduced need for physiotherapy follow-up and quicker discharge from the service). The qualitative component of this study will capture both patients and clinician perspectives of the safety, suitability and acceptability of the intervention and outcome measures and will assist in adapting the study elements prior to a full randomised control trial to test the effectiveness of prehabilitation in this population. This study is conducted within a tertiary NHS setting and therefore can be reproduced and applied in similar healthcare settings.</p>
</sec>
<sec id="sec050">
<title>Limitations of the study</title>
<p>There are several limitations to this study. The number of study participants has been selected to test the feasibility and to be able to perform a sample size calculation to determine the number of participants required for a definitive trial. Therefore, these results should be considered as preliminary findings. The study is conducted in a single tertiary hospital in the UK and therefore may need to be adapted prior to wider implementation in other healthcare services across the globe. As this is a feasibility study, the impact of this study on patient care and NHS costs cannot be understood fully and may not change practice. However, if found successful further funding will be sought out for a future definite trial to test its effectiveness.</p>
</sec>
<sec id="sec051" sec-type="conclusions">
<title>Discussion</title>
<p>Despite the exponential growth and development of innovative surgical interventions for FAIS, it is estimated that nearly half (49%) receiving hip arthroscopy do not achieve optimal outcomes [<xref ref-type="bibr" rid="pone.0301194.ref010">10</xref>]. A recent retrospective analysis of more than 4900 patients from the Non-arthroplasty Hip Registry in the UK reported that almost 35% patients undergoing hip arthroscopy for FAIS did not achieve the MCID of 13 points and only 50% achieved substantial clinical benefit (SCB) of 28 points on the iHOT-12 at 12 months post-op [<xref ref-type="bibr" rid="pone.0301194.ref008">8</xref>]. Deficits in muscle strength and ROM in patients with FAI is well evidenced in the literature [<xref ref-type="bibr" rid="pone.0301194.ref015">15</xref>, <xref ref-type="bibr" rid="pone.0301194.ref080">80</xref>]. Additionally, pandemic outbreaks like COVID-19 has placed an unprecedented delay on elective operations leading to further chronicity and deconditioning in patients [<xref ref-type="bibr" rid="pone.0301194.ref081">81</xref>]. Therefore, optimising patients through effective prehabilitation programmes might play a vital role in early identification of impairments and promote physical and psychological wellbeing prior to undergoing surgery [<xref ref-type="bibr" rid="pone.0301194.ref082">82</xref>]. However, the role of exercise interventions prior to surgery in FAIS is under explored. This study will provide important preliminary data to inform feasibility of a definitive RCT in the future to evaluate effectiveness of a prehabilitation intervention. Additionally, the study will record adherence, adverse effects and satisfaction of the prehabilitation programme which are important elements at the feasibility stage [<xref ref-type="bibr" rid="pone.0301194.ref025">25</xref>].</p>
<p>It is anticipated that this programme will eventually lead to improvement in the delivery of FAIS care, reduce social and healthcare costs and assist in targeting and optimising patients much earlier in their clinical pathway.</p>
</sec>
<sec id="sec052" sec-type="supplementary-material">
<title>Supporting information</title>
<supplementary-material id="pone.0301194.s001" mimetype="application/vnd.openxmlformats-officedocument.wordprocessingml.document" position="float" xlink:href="pone.0301194.s001.docx" xlink:type="simple">
<label>S1 Appendix</label>
<caption>
<title>Details of the prehabilitation intervention.</title>
<p>(DOCX)</p>
</caption>
</supplementary-material>
<supplementary-material id="pone.0301194.s002" mimetype="application/vnd.openxmlformats-officedocument.wordprocessingml.document" position="float" xlink:href="pone.0301194.s002.docx" xlink:type="simple">
<label>S2 Appendix</label>
<caption>
<title>Sample consent form.</title>
<p>(DOCX)</p>
</caption>
</supplementary-material>
<supplementary-material id="pone.0301194.s003" mimetype="application/vnd.openxmlformats-officedocument.wordprocessingml.document" position="float" xlink:href="pone.0301194.s003.docx" xlink:type="simple">
<label>S3 Appendix</label>
<caption>
<title>Objective outcome measurements.</title>
<p>(DOCX)</p>
</caption>
</supplementary-material>
<supplementary-material id="pone.0301194.s004" mimetype="application/msword" position="float" xlink:href="pone.0301194.s004.doc" xlink:type="simple">
<label>S4 Appendix</label>
<caption>
<title>SPIRIT checklist.</title>
<p>(DOC)</p>
</caption>
</supplementary-material>
<supplementary-material id="pone.0301194.s005" mimetype="application/vnd.openxmlformats-officedocument.wordprocessingml.document" position="float" xlink:href="pone.0301194.s005.docx" xlink:type="simple">
<label>S1 File</label>
<caption>
<title/>
<p>(DOCX)</p>
</caption>
</supplementary-material>
</sec>
</body>
<back>
<ack>
<p>The authors would like to thank the Physiotherapy Department based at Addenbrooke’s Hospital, Cambridge for their support in delivering the intervention for the study. The authors would also like to thank Physitrack PLC for permitting the use of the images.</p>
</ack>
<ref-list>
<title>References</title>
<ref id="pone.0301194.ref001"><label>1</label><mixed-citation publication-type="journal" xlink:type="simple"><name><surname>Griffin</surname> <given-names>DR</given-names></name>, <name><surname>Dickenson</surname> <given-names>EJ</given-names></name>, <name><surname>O’Donnell</surname> <given-names>J</given-names></name>, <name><surname>Agricola</surname> <given-names>R</given-names></name>, <name><surname>Awan</surname> <given-names>T</given-names></name>, <name><surname>Beck</surname> <given-names>M</given-names></name>, <etal>et al</etal>. <article-title>The Warwick Agreement on femoroacetabular impingement syndrome (FAI syndrome): an international consensus statement</article-title>. <source>Br J Sports Med</source>. <year>2016</year>;<volume>50</volume>(<issue>19</issue>):<fpage>1169</fpage>–<lpage>76</lpage>. Epub 2016/09/16. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1136/bjsports-2016-096743" xlink:type="simple">10.1136/bjsports-2016-096743</ext-link></comment> <object-id pub-id-type="pmid">27629403</object-id>.</mixed-citation></ref>
<ref id="pone.0301194.ref002"><label>2</label><mixed-citation publication-type="journal" xlink:type="simple"><name><surname>Viswanath</surname> <given-names>A</given-names></name>, <name><surname>Khanduja</surname> <given-names>V</given-names></name>. <article-title>Can hip arthroscopy in the presence of arthritis delay the need for hip arthroplasty?</article-title> <source>J Hip Preserv Surg</source>. <year>2017</year>;<volume>4</volume>(<issue>1</issue>):<fpage>3</fpage>–<lpage>8</lpage>. Epub 2017/06/21. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1093/jhps/hnw050" xlink:type="simple">10.1093/jhps/hnw050</ext-link></comment> <object-id pub-id-type="pmid">28630715</object-id>.</mixed-citation></ref>
<ref id="pone.0301194.ref003"><label>3</label><mixed-citation publication-type="journal" xlink:type="simple"><name><surname>Dickenson</surname> <given-names>EJ</given-names></name>, <name><surname>Wall</surname> <given-names>PDH</given-names></name>, <name><surname>Hutchinson</surname> <given-names>CE</given-names></name>, <name><surname>Griffin</surname> <given-names>DR</given-names></name>. <article-title>The prevalence of cam hip morphology in a general population sample</article-title>. <source>Osteoarthritis Cartilage</source>. <year>2019</year>;<volume>27</volume>(<issue>3</issue>):<fpage>444</fpage>–<lpage>8</lpage>. Epub 2018/12/07. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1016/j.joca.2018.09.019" xlink:type="simple">10.1016/j.joca.2018.09.019</ext-link></comment> <object-id pub-id-type="pmid">30502450</object-id>.</mixed-citation></ref>
<ref id="pone.0301194.ref004"><label>4</label><mixed-citation publication-type="journal" xlink:type="simple"><name><surname>Lewis</surname> <given-names>CL</given-names></name>, <name><surname>Sahrmann</surname> <given-names>SA</given-names></name>, <name><surname>Moran</surname> <given-names>DW</given-names></name>. <article-title>Anterior hip joint force increases with hip extension, decreased gluteal force, or decreased iliopsoas force</article-title>. <source>J Biomech</source>. <year>2007</year>;<volume>40</volume>(<issue>16</issue>):<fpage>3725</fpage>–<lpage>31</lpage>. Epub 2007/08/21. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1016/j.jbiomech.2007.06.024" xlink:type="simple">10.1016/j.jbiomech.2007.06.024</ext-link></comment> <object-id pub-id-type="pmid">17707385</object-id>.</mixed-citation></ref>
<ref id="pone.0301194.ref005"><label>5</label><mixed-citation publication-type="journal" xlink:type="simple"><name><surname>Alshameeri</surname> <given-names>Z</given-names></name>, <name><surname>Khanduja</surname> <given-names>V</given-names></name>. <article-title>The effect of femoro-acetabular impingement on the kinematics and kinetics of the hip joint</article-title>. <source>Int Orthop</source>. <year>2014</year>;<volume>38</volume>(<issue>8</issue>):<fpage>1615</fpage>–<lpage>20</lpage>. Epub 2014/04/02. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1007/s00264-014-2302-5" xlink:type="simple">10.1007/s00264-014-2302-5</ext-link></comment> <object-id pub-id-type="pmid">24687267</object-id>.</mixed-citation></ref>
<ref id="pone.0301194.ref006"><label>6</label><mixed-citation publication-type="journal" xlink:type="simple"><name><surname>Kemp</surname> <given-names>JL</given-names></name>, <name><surname>Johnston</surname> <given-names>RTR</given-names></name>, <name><surname>Coburn</surname> <given-names>SL</given-names></name>, <name><surname>Jones</surname> <given-names>DM</given-names></name>, <name><surname>Schache</surname> <given-names>AG</given-names></name>, <name><surname>Mentiplay</surname> <given-names>BF</given-names></name>, <etal>et al</etal>. <article-title>Physiotherapist-led treatment for femoroacetabular impingement syndrome (the PhysioFIRST study): a protocol for a participant and assessor-blinded randomised controlled trial</article-title>. <source>BMJ Open</source>. <year>2021</year>;<volume>11</volume>(<issue>4</issue>):<fpage>e041742</fpage>. Epub 2021/04/09. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1136/bmjopen-2020-041742" xlink:type="simple">10.1136/bmjopen-2020-041742</ext-link></comment> <object-id pub-id-type="pmid">33827828</object-id>.</mixed-citation></ref>
<ref id="pone.0301194.ref007"><label>7</label><mixed-citation publication-type="journal" xlink:type="simple"><name><surname>Andronic</surname> <given-names>O</given-names></name>, <name><surname>Claydon-Mueller</surname> <given-names>LS</given-names></name>, <name><surname>Cubberley</surname> <given-names>R</given-names></name>, <name><surname>Karczewski</surname> <given-names>D</given-names></name>, <name><surname>Lu</surname> <given-names>V</given-names></name>, <name><surname>Khanduja</surname> <given-names>V</given-names></name>. <article-title>No evidence exists on outcomes of non-operative management in patients with femoroacetabular impingement and concomitant Tonnis Grade 2 or more hip osteoarthritis: a scoping review</article-title>. <source>Knee Surg Sports Traumatol Arthrosc</source>. <year>2023</year>;<volume>31</volume>(<issue>6</issue>):<fpage>2103</fpage>–<lpage>22</lpage>. Epub 2022/12/10. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1007/s00167-022-07274-y" xlink:type="simple">10.1007/s00167-022-07274-y</ext-link></comment> <object-id pub-id-type="pmid">36484811</object-id>.</mixed-citation></ref>
<ref id="pone.0301194.ref008"><label>8</label><mixed-citation publication-type="journal" xlink:type="simple"><name><surname>Holleyman</surname> <given-names>R</given-names></name>, <name><surname>Sohatee</surname> <given-names>MA</given-names></name>, <name><surname>Lyman</surname> <given-names>S</given-names></name>, <name><surname>Malviya</surname> <given-names>A</given-names></name>, <name><surname>Khanduja</surname> <given-names>V</given-names></name>, <name><surname>Group</surname> <given-names>NU</given-names></name>. <article-title>Hip arthroscopy for femoroacetabular impingement is associated with significant improvement in early patient reported outcomes: analysis of 4963 cases from the UK non-arthroplasty registry (NAHR) dataset</article-title>. <source>Knee Surg Sports Traumatol Arthrosc</source>. <year>2023</year>;<volume>31</volume>(<issue>1</issue>):<fpage>58</fpage>–<lpage>69</lpage>. Epub 2022/07/15. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1007/s00167-022-07042-y" xlink:type="simple">10.1007/s00167-022-07042-y</ext-link></comment> <object-id pub-id-type="pmid">35833961</object-id>.</mixed-citation></ref>
<ref id="pone.0301194.ref009"><label>9</label><mixed-citation publication-type="journal" xlink:type="simple"><name><surname>Palmer</surname> <given-names>AJ</given-names></name>, <name><surname>Malak</surname> <given-names>TT</given-names></name>, <name><surname>Broomfield</surname> <given-names>J</given-names></name>, <name><surname>Holton</surname> <given-names>J</given-names></name>, <name><surname>Majkowski</surname> <given-names>L</given-names></name>, <name><surname>Thomas</surname> <given-names>GE</given-names></name>, <etal>et al</etal>. <article-title>Past and projected temporal trends in arthroscopic hip surgery in England between 2002 and 2013</article-title>. <source>BMJ Open Sport Exerc Med</source>. <year>2016</year>;<volume>2</volume>(<issue>1</issue>):<fpage>e000082</fpage>. Epub 2016/12/03. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1136/bmjsem-2015-000082" xlink:type="simple">10.1136/bmjsem-2015-000082</ext-link></comment> <object-id pub-id-type="pmid">27900161</object-id>.</mixed-citation></ref>
<ref id="pone.0301194.ref010"><label>10</label><mixed-citation publication-type="journal" xlink:type="simple"><name><surname>Griffin</surname> <given-names>DR</given-names></name>, <name><surname>Dickenson</surname> <given-names>EJ</given-names></name>, <name><surname>Wall</surname> <given-names>PDH</given-names></name>, <name><surname>Achana</surname> <given-names>F</given-names></name>, <name><surname>Donovan</surname> <given-names>JL</given-names></name>, <name><surname>Griffin</surname> <given-names>J</given-names></name>, <etal>et al</etal>. <article-title>Hip arthroscopy versus best conservative care for the treatment of femoroacetabular impingement syndrome (UK FASHIoN): a multicentre randomised controlled trial</article-title>. <source>Lancet</source>. <year>2018</year>;<volume>391</volume>(<issue>10136</issue>):<fpage>2225</fpage>–<lpage>35</lpage>. Epub 2018/06/13. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1016/S0140-6736%2818%2931202-9" xlink:type="simple">10.1016/S0140-6736(18)31202-9</ext-link></comment> <object-id pub-id-type="pmid">29893223</object-id>.</mixed-citation></ref>
<ref id="pone.0301194.ref011"><label>11</label><mixed-citation publication-type="journal" xlink:type="simple"><name><surname>Palmer</surname> <given-names>AJR</given-names></name>, <name><surname>Ayyar Gupta</surname> <given-names>V</given-names></name>, <name><surname>Fernquest</surname> <given-names>S</given-names></name>, <name><surname>Rombach</surname> <given-names>I</given-names></name>, <name><surname>Dutton</surname> <given-names>SJ</given-names></name>, <name><surname>Mansour</surname> <given-names>R</given-names></name>, <etal>et al</etal>. <article-title>Arthroscopic hip surgery compared with physiotherapy and activity modification for the treatment of symptomatic femoroacetabular impingement: multicentre randomised controlled trial</article-title>. <source>BMJ</source>. <year>2019</year>;<volume>364</volume>:<fpage>l185</fpage>. Epub 2019/02/09. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1136/bmj.l185" xlink:type="simple">10.1136/bmj.l185</ext-link></comment> <object-id pub-id-type="pmid">30733197</object-id></mixed-citation></ref>
<ref id="pone.0301194.ref012"><label>12</label><mixed-citation publication-type="journal" xlink:type="simple"><name><surname>Shin</surname> <given-names>JJ</given-names></name>, <name><surname>de Sa</surname> <given-names>DL</given-names></name>, <name><surname>Burnham</surname> <given-names>JM</given-names></name>, <name><surname>Mauro</surname> <given-names>CS</given-names></name>. <article-title>Refractory pain following hip arthroscopy: evaluation and management</article-title>. <source>J Hip Preserv Surg</source>. <year>2018</year>;<volume>5</volume>(<issue>1</issue>):<fpage>3</fpage>–<lpage>14</lpage>. Epub 2018/02/10. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1093/jhps/hnx047" xlink:type="simple">10.1093/jhps/hnx047</ext-link></comment> <object-id pub-id-type="pmid">29423245</object-id>.</mixed-citation></ref>
<ref id="pone.0301194.ref013"><label>13</label><mixed-citation publication-type="journal" xlink:type="simple"><name><surname>Kuroda</surname> <given-names>Y</given-names></name>, <name><surname>Saito</surname> <given-names>M</given-names></name>, <name><surname>Cinar</surname> <given-names>EN</given-names></name>, <name><surname>Norrish</surname> <given-names>A</given-names></name>, <name><surname>Khanduja</surname> <given-names>V</given-names></name>. <article-title>Patient-related risk factors associated with less favourable outcomes following hip arthroscopy</article-title>. <source>Bone Joint J</source>. <year>2020</year>;<volume>102-B</volume>(<issue>7</issue>):<fpage>822</fpage>–<lpage>31</lpage>. Epub 2020/07/01. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1302/0301-620X.102B7.BJJ-2020-0031.R1" xlink:type="simple">10.1302/0301-620X.102B7.BJJ-2020-0031.R1</ext-link></comment> <object-id pub-id-type="pmid">32600150</object-id>.</mixed-citation></ref>
<ref id="pone.0301194.ref014"><label>14</label><mixed-citation publication-type="journal" xlink:type="simple"><name><surname>Basques</surname> <given-names>BA</given-names></name>, <name><surname>Waterman</surname> <given-names>BR</given-names></name>, <name><surname>Ukwuani</surname> <given-names>G</given-names></name>, <name><surname>Beck</surname> <given-names>EC</given-names></name>, <name><surname>Neal</surname> <given-names>WH</given-names></name>, <name><surname>Friel</surname> <given-names>NA</given-names></name>, <etal>et al</etal>. <article-title>Preoperative Symptom Duration Is Associated With Outcomes After Hip Arthroscopy</article-title>. <source>Am J Sports Med</source>. <year>2019</year>;<volume>47</volume>(<issue>1</issue>):<fpage>131</fpage>–<lpage>7</lpage>. Epub 2018/11/30. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1177/0363546518808046" xlink:type="simple">10.1177/0363546518808046</ext-link></comment> <object-id pub-id-type="pmid">30484686</object-id>.</mixed-citation></ref>
<ref id="pone.0301194.ref015"><label>15</label><mixed-citation publication-type="journal" xlink:type="simple"><name><surname>Freke</surname> <given-names>MD</given-names></name>, <name><surname>Kemp</surname> <given-names>J</given-names></name>, <name><surname>Svege</surname> <given-names>I</given-names></name>, <name><surname>Risberg</surname> <given-names>MA</given-names></name>, <name><surname>Semciw</surname> <given-names>A</given-names></name>, <name><surname>Crossley</surname> <given-names>KM</given-names></name>. <article-title>Physical impairments in symptomatic femoroacetabular impingement: a systematic review of the evidence</article-title>. <source>Br J Sports Med</source>. <year>2016</year>;<volume>50</volume>(<issue>19</issue>):<fpage>1180</fpage>. Epub 2016/06/16. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1136/bjsports-2016-096152" xlink:type="simple">10.1136/bjsports-2016-096152</ext-link></comment> <object-id pub-id-type="pmid">27301577</object-id>.</mixed-citation></ref>
<ref id="pone.0301194.ref016"><label>16</label><mixed-citation publication-type="journal" xlink:type="simple"><name><surname>Martin</surname> <given-names>RL</given-names></name>, <name><surname>Christoforetti</surname> <given-names>JJ</given-names></name>, <name><surname>McGovern</surname> <given-names>R</given-names></name>, <name><surname>Kivlan</surname> <given-names>BR</given-names></name>, <name><surname>Wolff</surname> <given-names>AB</given-names></name>, <name><surname>Nho</surname> <given-names>SJ</given-names></name>, <etal>et al</etal>. <article-title>The Impact of Depression on Patient Outcomes in Hip Arthroscopic Surgery</article-title>. <source>Orthop J Sports Med</source>. <year>2018</year>;<volume>6</volume>(<issue>11</issue>):<fpage>2325967118806490</fpage>. Epub 2018/11/28. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1177/2325967118806490" xlink:type="simple">10.1177/2325967118806490</ext-link></comment> <object-id pub-id-type="pmid">30480015</object-id>.</mixed-citation></ref>
<ref id="pone.0301194.ref017"><label>17</label><mixed-citation publication-type="journal" xlink:type="simple"><name><surname>Sunil Kumar</surname> <given-names>KH</given-names></name>, <name><surname>Rawal</surname> <given-names>J</given-names></name>, <name><surname>Nakano</surname> <given-names>N</given-names></name>, <name><surname>Sarmento</surname> <given-names>A</given-names></name>, <name><surname>Khanduja</surname> <given-names>V</given-names></name>. <article-title>Pathogenesis and contemporary diagnoses for lateral hip pain: a scoping review</article-title>. <source>Knee Surg Sports Traumatol Arthrosc</source>. <year>2021</year>;<volume>29</volume>(<issue>8</issue>):<fpage>2408</fpage>–<lpage>16</lpage>. Epub 2020/12/21. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1007/s00167-020-06354-1" xlink:type="simple">10.1007/s00167-020-06354-1</ext-link></comment> <object-id pub-id-type="pmid">33341914</object-id>.</mixed-citation></ref>
<ref id="pone.0301194.ref018"><label>18</label><mixed-citation publication-type="journal" xlink:type="simple"><name><surname>Hammoud</surname> <given-names>S</given-names></name>, <name><surname>Bedi</surname> <given-names>A</given-names></name>, <name><surname>Magennis</surname> <given-names>E</given-names></name>, <name><surname>Meyers</surname> <given-names>WC</given-names></name>, <name><surname>Kelly</surname> <given-names>BT</given-names></name>. <article-title>High incidence of athletic pubalgia symptoms in professional athletes with symptomatic femoroacetabular impingement</article-title>. <source>Arthroscopy</source>. <year>2012</year>;<volume>28</volume>(<issue>10</issue>):<fpage>1388</fpage>–<lpage>95</lpage>. Epub 2012/05/23. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1016/j.arthro.2012.02.024" xlink:type="simple">10.1016/j.arthro.2012.02.024</ext-link></comment> <object-id pub-id-type="pmid">22608890</object-id>.</mixed-citation></ref>
<ref id="pone.0301194.ref019"><label>19</label><mixed-citation publication-type="journal" xlink:type="simple"><name><surname>Ditmyer</surname> <given-names>MM</given-names></name>, <name><surname>Topp</surname> <given-names>R</given-names></name>, <name><surname>Pifer</surname> <given-names>M</given-names></name>. <article-title>Prehabilitation in preparation for orthopaedic surgery</article-title>. <source>Orthop Nurs</source>. <year>2002</year>;<volume>21</volume>(<issue>5</issue>):<fpage>43</fpage>–<lpage>51</lpage>; quiz 2–4. Epub 2002/11/16. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1097/00006416-200209000-00008" xlink:type="simple">10.1097/00006416-200209000-00008</ext-link></comment> <object-id pub-id-type="pmid">12432699</object-id>.</mixed-citation></ref>
<ref id="pone.0301194.ref020"><label>20</label><mixed-citation publication-type="journal" xlink:type="simple"><name><surname>Durrand</surname> <given-names>J</given-names></name>, <name><surname>Singh</surname> <given-names>SJ</given-names></name>, <name><surname>Danjoux</surname> <given-names>G</given-names></name>. <article-title>Prehabilitation</article-title>. <source>Clin Med (Lond)</source>. <year>2019</year>;<volume>19</volume>(<issue>6</issue>):<fpage>458</fpage>–<lpage>64</lpage>. Epub 2019/11/17. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.7861/clinmed.2019-0257" xlink:type="simple">10.7861/clinmed.2019-0257</ext-link></comment> <object-id pub-id-type="pmid">31732585</object-id>.</mixed-citation></ref>
<ref id="pone.0301194.ref021"><label>21</label><mixed-citation publication-type="journal" xlink:type="simple"><name><surname>Punnoose</surname> <given-names>A</given-names></name>, <name><surname>Claydon-Mueller</surname> <given-names>LS</given-names></name>, <name><surname>Weiss</surname> <given-names>O</given-names></name>, <name><surname>Zhang</surname> <given-names>J</given-names></name>, <name><surname>Rushton</surname> <given-names>A</given-names></name>, <name><surname>Khanduja</surname> <given-names>V</given-names></name>. <article-title>Prehabilitation for Patients Undergoing Orthopedic Surgery: A Systematic Review and Meta-analysis</article-title>. <source>JAMA Netw Open</source>. <year>2023</year>;<volume>6</volume>(<issue>4</issue>):<fpage>e238050</fpage>. Epub 2023/04/14. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1001/jamanetworkopen.2023.8050" xlink:type="simple">10.1001/jamanetworkopen.2023.8050</ext-link></comment> <object-id pub-id-type="pmid">37052919</object-id>.</mixed-citation></ref>
<ref id="pone.0301194.ref022"><label>22</label><mixed-citation publication-type="journal" xlink:type="simple"><name><surname>McDonald</surname> <given-names>S</given-names></name>, <name><surname>Yates</surname> <given-names>D</given-names></name>, <name><surname>Durrand</surname> <given-names>JW</given-names></name>, <name><surname>Kothmann</surname> <given-names>E</given-names></name>, <name><surname>Sniehotta</surname> <given-names>FF</given-names></name>, <name><surname>Habgood</surname> <given-names>A</given-names></name>, <etal>et al</etal>. <article-title>Exploring patient attitudes to behaviour change before surgery to reduce peri-operative risk: preferences for short- vs. long-term behaviour change</article-title>. <source>Anaesthesia</source>. <year>2019</year>;<volume>74</volume>(<issue>12</issue>):<fpage>1580</fpage>–<lpage>8</lpage>. Epub 2019/10/23. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1111/anae.14826" xlink:type="simple">10.1111/anae.14826</ext-link></comment> <object-id pub-id-type="pmid">31637700</object-id>.</mixed-citation></ref>
<ref id="pone.0301194.ref023"><label>23</label><mixed-citation publication-type="journal" xlink:type="simple"><name><surname>Grant</surname> <given-names>LF</given-names></name>, <name><surname>Cooper</surname> <given-names>DJ</given-names></name>, <name><surname>Conroy</surname> <given-names>JL</given-names></name>. <article-title>The HAPI ’Hip Arthroscopy Pre-habilitation Intervention’ study: does pre-habilitation affect outcomes in patients undergoing hip arthroscopy for femoro-acetabular impingement?</article-title> <source>J Hip Preserv Surg</source>. <year>2017</year>;<volume>4</volume>(<issue>1</issue>):<fpage>85</fpage>–<lpage>92</lpage>. Epub 2017/06/21. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1093/jhps/hnw046" xlink:type="simple">10.1093/jhps/hnw046</ext-link></comment> <object-id pub-id-type="pmid">28630726</object-id>.</mixed-citation></ref>
<ref id="pone.0301194.ref024"><label>24</label><mixed-citation publication-type="journal" xlink:type="simple"><name><surname>Room</surname> <given-names>J</given-names></name>, <name><surname>Hannink</surname> <given-names>E</given-names></name>, <name><surname>Dawes</surname> <given-names>H</given-names></name>, <name><surname>Barker</surname> <given-names>K</given-names></name>. <article-title>What interventions are used to improve exercise adherence in older people and what behavioural techniques are they based on? A systematic review</article-title>. <source>BMJ Open</source>. <year>2017</year>;<volume>7</volume>(<issue>12</issue>):<fpage>e019221</fpage>. Epub 2017/12/17. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1136/bmjopen-2017-019221" xlink:type="simple">10.1136/bmjopen-2017-019221</ext-link></comment> <object-id pub-id-type="pmid">29247111</object-id>.</mixed-citation></ref>
<ref id="pone.0301194.ref025"><label>25</label><mixed-citation publication-type="journal" xlink:type="simple"><name><surname>Tickle-Degnen</surname> <given-names>L</given-names></name>. <article-title>Nuts and bolts of conducting feasibility studies</article-title>. <source>Am J Occup Ther</source>. <year>2013</year>;<volume>67</volume>(<issue>2</issue>):<fpage>171</fpage>–<lpage>6</lpage>. Epub 2013/02/26. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.5014/ajot.2013.006270" xlink:type="simple">10.5014/ajot.2013.006270</ext-link></comment> <object-id pub-id-type="pmid">23433271</object-id>.</mixed-citation></ref>
<ref id="pone.0301194.ref026"><label>26</label><mixed-citation publication-type="journal" xlink:type="simple"><name><surname>Bangor</surname> <given-names>A</given-names></name>, <name><surname>Kortum</surname> <given-names>PT</given-names></name>, <name><surname>Miller</surname> <given-names>JT</given-names></name>. <article-title>An Empirical Evaluation of the System Usability Scale</article-title>. <source>International Journal of Human–Computer Interaction</source>. <year>2008</year>;<volume>24</volume>(<issue>6</issue>):<fpage>574</fpage>–<lpage>94</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1080/10447310802205776" xlink:type="simple">10.1080/10447310802205776</ext-link></comment></mixed-citation></ref>
<ref id="pone.0301194.ref027"><label>27</label><mixed-citation publication-type="journal" xlink:type="simple"><name><surname>El-Kotob</surname> <given-names>R</given-names></name>, <name><surname>Giangregorio</surname> <given-names>LM</given-names></name>. <article-title>Pilot and feasibility studies in exercise, physical activity, or rehabilitation research</article-title>. <source>Pilot Feasibility Stud</source>. <year>2018</year>;<volume>4</volume>:<fpage>137</fpage>. Epub 2018/08/21. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1186/s40814-018-0326-0" xlink:type="simple">10.1186/s40814-018-0326-0</ext-link></comment> <object-id pub-id-type="pmid">30123527</object-id>.</mixed-citation></ref>
<ref id="pone.0301194.ref028"><label>28</label><mixed-citation publication-type="journal" xlink:type="simple"><name><surname>Arain</surname> <given-names>M</given-names></name>, <name><surname>Campbell</surname> <given-names>MJ</given-names></name>, <name><surname>Cooper</surname> <given-names>CL</given-names></name>, <name><surname>Lancaster</surname> <given-names>GA</given-names></name>. <article-title>What is a pilot or feasibility study? A review of current practice and editorial policy</article-title>. <source>BMC Med Res Methodol</source>. <year>2010</year>;<volume>10</volume>:<fpage>67</fpage>. Epub 2010/07/20. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1186/1471-2288-10-67" xlink:type="simple">10.1186/1471-2288-10-67</ext-link></comment> <object-id pub-id-type="pmid">20637084</object-id>.</mixed-citation></ref>
<ref id="pone.0301194.ref029"><label>29</label><mixed-citation publication-type="journal" xlink:type="simple"><name><surname>Bowen</surname> <given-names>DJ</given-names></name>, <name><surname>Kreuter</surname> <given-names>M</given-names></name>, <name><surname>Spring</surname> <given-names>B</given-names></name>, <name><surname>Cofta-Woerpel</surname> <given-names>L</given-names></name>, <name><surname>Linnan</surname> <given-names>L</given-names></name>, <name><surname>Weiner</surname> <given-names>D</given-names></name>, <etal>et al</etal>. <article-title>How we design feasibility studies</article-title>. <source>Am J Prev Med</source>. <year>2009</year>;<volume>36</volume>(<issue>5</issue>):<fpage>452</fpage>–<lpage>7</lpage>. Epub 2009/04/14. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1016/j.amepre.2009.02.002" xlink:type="simple">10.1016/j.amepre.2009.02.002</ext-link></comment> <object-id pub-id-type="pmid">19362699</object-id>.</mixed-citation></ref>
<ref id="pone.0301194.ref030"><label>30</label><mixed-citation publication-type="journal" xlink:type="simple"><name><surname>Eldridge</surname> <given-names>SM</given-names></name>, <name><surname>Chan</surname> <given-names>CL</given-names></name>, <name><surname>Campbell</surname> <given-names>MJ</given-names></name>, <name><surname>Bond</surname> <given-names>CM</given-names></name>, <name><surname>Hopewell</surname> <given-names>S</given-names></name>, <name><surname>Thabane</surname> <given-names>L</given-names></name>, <etal>et al</etal>. <article-title>CONSORT 2010 statement: extension to randomised pilot and feasibility trials</article-title>. <source>Pilot Feasibility Stud</source>. <year>2016</year>;<volume>2</volume>:<fpage>64</fpage>. Epub 2016/12/15. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1186/s40814-016-0105-8" xlink:type="simple">10.1186/s40814-016-0105-8</ext-link></comment> <object-id pub-id-type="pmid">27965879</object-id>.</mixed-citation></ref>
<ref id="pone.0301194.ref031"><label>31</label><mixed-citation publication-type="journal" xlink:type="simple"><name><surname>Hariton</surname> <given-names>E</given-names></name>, <name><surname>Locascio</surname> <given-names>JJ</given-names></name>. <article-title>Randomised controlled trials—the gold standard for effectiveness research: Study design: randomised controlled trials</article-title>. <source>BJOG</source>. <year>2018</year>;<volume>125</volume>(<issue>13</issue>):<fpage>1716</fpage>. Epub 2018/06/20. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1111/1471-0528.15199" xlink:type="simple">10.1111/1471-0528.15199</ext-link></comment> <object-id pub-id-type="pmid">29916205</object-id>.</mixed-citation></ref>
<ref id="pone.0301194.ref032"><label>32</label><mixed-citation publication-type="journal" xlink:type="simple"><name><surname>Craig</surname> <given-names>P</given-names></name>, <name><surname>Dieppe</surname> <given-names>P</given-names></name>, <name><surname>Macintyre</surname> <given-names>S</given-names></name>, <name><surname>Michie</surname> <given-names>S</given-names></name>, <name><surname>Nazareth</surname> <given-names>I</given-names></name>, <name><surname>Petticrew</surname> <given-names>M</given-names></name>. <article-title>Developing and evaluating complex interventions: the new Medical Research Council guidance</article-title>. <source>Int J Nurs Stud</source>. <year>2013</year>;<volume>50</volume>(<issue>5</issue>):<fpage>587</fpage>–<lpage>92</lpage>. Epub 2012/11/20. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1016/j.ijnurstu.2012.09.010" xlink:type="simple">10.1016/j.ijnurstu.2012.09.010</ext-link></comment> <object-id pub-id-type="pmid">23159157</object-id>.</mixed-citation></ref>
<ref id="pone.0301194.ref033"><label>33</label><mixed-citation publication-type="journal" xlink:type="simple"><name><surname>Hoddinott</surname> <given-names>P</given-names></name>. <article-title>A new era for intervention development studies</article-title>. <source>Pilot Feasibility Stud</source>. <year>2015</year>;<volume>1</volume>:<fpage>36</fpage>. Epub 2015/10/26. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1186/s40814-015-0032-0" xlink:type="simple">10.1186/s40814-015-0032-0</ext-link></comment> <object-id pub-id-type="pmid">27965814</object-id>.</mixed-citation></ref>
<ref id="pone.0301194.ref034"><label>34</label><mixed-citation publication-type="book" xlink:type="simple"><name><surname>Punnoose</surname> <given-names>A</given-names></name>, <name><surname>Khanduja</surname> <given-names>V</given-names></name>, <source>PrehabFAIpanel. Prehabilitation in patients with Femoroacetabular Impingement Syndrome undergoing arthroscopic surgery of the Hip—an International Consensus Statement ISHA Annual Scientific meeting</source>; <publisher-loc>Cape Town, South Africa</publisher-loc> <year>2023</year>.</mixed-citation></ref>
<ref id="pone.0301194.ref035"><label>35</label><mixed-citation publication-type="journal" xlink:type="simple"><name><surname>Harris</surname> <given-names>PA</given-names></name>, <name><surname>Taylor</surname> <given-names>R</given-names></name>, <name><surname>Thielke</surname> <given-names>R</given-names></name>, <name><surname>Payne</surname> <given-names>J</given-names></name>, <name><surname>Gonzalez</surname> <given-names>N</given-names></name>, <name><surname>Conde</surname> <given-names>JG</given-names></name>. <article-title>Research electronic data capture (REDCap)—a metadata-driven methodology and workflow process for providing translational research informatics support</article-title>. <source>J Biomed Inform</source>. <year>2009</year>;<volume>42</volume>(<issue>2</issue>):<fpage>377</fpage>–<lpage>81</lpage>. Epub 2008/10/22. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1016/j.jbi.2008.08.010" xlink:type="simple">10.1016/j.jbi.2008.08.010</ext-link></comment> <object-id pub-id-type="pmid">18929686</object-id>.</mixed-citation></ref>
<ref id="pone.0301194.ref036"><label>36</label><mixed-citation publication-type="journal" xlink:type="simple"><name><surname>Harris</surname> <given-names>PA</given-names></name>, <name><surname>Taylor</surname> <given-names>R</given-names></name>, <name><surname>Minor</surname> <given-names>BL</given-names></name>, <name><surname>Elliott</surname> <given-names>V</given-names></name>, <name><surname>Fernandez</surname> <given-names>M</given-names></name>, <name><surname>O’Neal</surname> <given-names>L</given-names></name>, <etal>et al</etal>. <article-title>The REDCap consortium: Building an international community of software platform partners</article-title>. <source>J Biomed Inform</source>. <year>2019</year>;<volume>95</volume>:<fpage>103208</fpage>. Epub 2019/05/13. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1016/j.jbi.2019.103208" xlink:type="simple">10.1016/j.jbi.2019.103208</ext-link></comment> <object-id pub-id-type="pmid">31078660</object-id>.</mixed-citation></ref>
<ref id="pone.0301194.ref037"><label>37</label><mixed-citation publication-type="journal" xlink:type="simple"><name><surname>Hoffmann</surname> <given-names>TC</given-names></name>, <name><surname>Glasziou</surname> <given-names>PP</given-names></name>, <name><surname>Boutron</surname> <given-names>I</given-names></name>, <name><surname>Milne</surname> <given-names>R</given-names></name>, <name><surname>Perera</surname> <given-names>R</given-names></name>, <name><surname>Moher</surname> <given-names>D</given-names></name>, <etal>et al</etal>. <article-title>Better reporting of interventions: template for intervention description and replication (TIDieR) checklist and guide</article-title>. <source>BMJ</source>. <year>2014</year>;<volume>348</volume>:<fpage>g1687</fpage>. Epub 2014/03/13. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1136/bmj.g1687" xlink:type="simple">10.1136/bmj.g1687</ext-link></comment> <object-id pub-id-type="pmid">24609605</object-id>.</mixed-citation></ref>
<ref id="pone.0301194.ref038"><label>38</label><mixed-citation publication-type="journal" xlink:type="simple"><name><surname>Sochacki</surname> <given-names>KR</given-names></name>, <name><surname>Brown</surname> <given-names>L</given-names></name>, <name><surname>Cenkus</surname> <given-names>K</given-names></name>, <name><surname>Di Stasi</surname> <given-names>S</given-names></name>, <name><surname>Harris</surname> <given-names>JD</given-names></name>, <name><surname>Ellis</surname> <given-names>TJ</given-names></name>. <article-title>Preoperative Depression Is Negatively Associated With Function and Predicts Poorer Outcomes After Hip Arthroscopy for Femoroacetabular Impingement</article-title>. <source>Arthroscopy</source>. <year>2018</year>;<volume>34</volume>(<issue>8</issue>):<fpage>2368</fpage>–<lpage>74</lpage>. Epub 2018/05/24. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1016/j.arthro.2018.03.020" xlink:type="simple">10.1016/j.arthro.2018.03.020</ext-link></comment> <object-id pub-id-type="pmid">29789247</object-id>.</mixed-citation></ref>
<ref id="pone.0301194.ref039"><label>39</label><mixed-citation publication-type="journal" xlink:type="simple"><name><surname>Bennell</surname> <given-names>KL</given-names></name>, <name><surname>Marshall</surname> <given-names>CJ</given-names></name>, <name><surname>Dobson</surname> <given-names>F</given-names></name>, <name><surname>Kasza</surname> <given-names>J</given-names></name>, <name><surname>Lonsdale</surname> <given-names>C</given-names></name>, <name><surname>Hinman</surname> <given-names>RS</given-names></name>. <article-title>Does a Web-Based Exercise Programming System Improve Home Exercise Adherence for People With Musculoskeletal Conditions?: A Randomized Controlled Trial</article-title>. <source>American Journal of Physical Medicine &amp; Rehabilitation</source>. <year>2019</year>;<volume>98</volume>(<issue>10</issue>). <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1097/PHM.0000000000001204" xlink:type="simple">10.1097/PHM.0000000000001204</ext-link></comment> <object-id pub-id-type="pmid">31021823</object-id></mixed-citation></ref>
<ref id="pone.0301194.ref040"><label>40</label><mixed-citation publication-type="journal" xlink:type="simple"><name><surname>Kuroda</surname> <given-names>Y</given-names></name>, <name><surname>Young</surname> <given-names>M</given-names></name>, <name><surname>Shoman</surname> <given-names>H</given-names></name>, <name><surname>Punnoose</surname> <given-names>A</given-names></name>, <name><surname>Norrish</surname> <given-names>AR</given-names></name>, <name><surname>Khanduja</surname> <given-names>V</given-names></name>. <source>Advanced Rehabilitation Technology In Orthopaedics—A Narrative Review</source>. <year>2020</year>.</mixed-citation></ref>
<ref id="pone.0301194.ref041"><label>41</label><mixed-citation publication-type="other" xlink:type="simple">GraphPad. <ext-link ext-link-type="uri" xlink:href="https://www.graphpad.com/quickcalcs/randomize1/" xlink:type="simple">https://www.graphpad.com/quickcalcs/randomize1/</ext-link>.</mixed-citation></ref>
<ref id="pone.0301194.ref042"><label>42</label><mixed-citation publication-type="journal" xlink:type="simple"><name><surname>Sussman</surname> <given-names>JB</given-names></name>, <name><surname>Hayward</surname> <given-names>RA</given-names></name>. <article-title>An IV for the RCT: using instrumental variables to adjust for treatment contamination in randomised controlled trials</article-title>. <source>BMJ</source>. <year>2010</year>;<volume>340</volume>:<fpage>c2073</fpage>. Epub 2010/05/06. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1136/bmj.c2073" xlink:type="simple">10.1136/bmj.c2073</ext-link></comment> <object-id pub-id-type="pmid">20442226</object-id>.</mixed-citation></ref>
<ref id="pone.0301194.ref043"><label>43</label><mixed-citation publication-type="journal" xlink:type="simple"><name><surname>Griffin</surname> <given-names>DR</given-names></name>, <name><surname>Parsons</surname> <given-names>N</given-names></name>, <name><surname>Mohtadi</surname> <given-names>NG</given-names></name>, <name><surname>Safran</surname> <given-names>MR</given-names></name>, <article-title>Multicenter Arthroscopy of the Hip Outcomes Research N. A short version of the International Hip Outcome Tool (iHOT-12) for use in routine clinical practice</article-title>. <source>Arthroscopy</source>. <year>2012</year>;<volume>28</volume>(<issue>5</issue>):<fpage>611</fpage>–<lpage>6</lpage>; quiz 6–8. Epub 2012/05/01. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1016/j.arthro.2012.02.027" xlink:type="simple">10.1016/j.arthro.2012.02.027</ext-link></comment> <object-id pub-id-type="pmid">22542434</object-id>.</mixed-citation></ref>
<ref id="pone.0301194.ref044"><label>44</label><mixed-citation publication-type="journal" xlink:type="simple"><name><surname>Nwachukwu</surname> <given-names>BU</given-names></name>, <name><surname>Chang</surname> <given-names>B</given-names></name>, <name><surname>Beck</surname> <given-names>EC</given-names></name>, <name><surname>Neal</surname> <given-names>WH</given-names></name>, <name><surname>Movassaghi</surname> <given-names>K</given-names></name>, <name><surname>Ranawat</surname> <given-names>AS</given-names></name>, <etal>et al</etal>. <article-title>How Should We Define Clinically Significant Outcome Improvement on the iHOT-12?</article-title> <source>HSS J</source>. <year>2019</year>;<volume>15</volume>(<issue>2</issue>):<fpage>103</fpage>–<lpage>8</lpage>. Epub 2019/07/23. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1007/s11420-018-9646-0" xlink:type="simple">10.1007/s11420-018-9646-0</ext-link></comment> <object-id pub-id-type="pmid">31327939</object-id>.</mixed-citation></ref>
<ref id="pone.0301194.ref045"><label>45</label><mixed-citation publication-type="journal" xlink:type="simple"><name><surname>Khayambashi</surname> <given-names>K</given-names></name>, <name><surname>Ghoddosi</surname> <given-names>N</given-names></name>, <name><surname>Straub</surname> <given-names>RK</given-names></name>, <name><surname>Powers</surname> <given-names>CM</given-names></name>. <article-title>Hip Muscle Strength Predicts Noncontact Anterior Cruciate Ligament Injury in Male and Female Athletes: A Prospective Study</article-title>. <source>Am J Sports Med</source>. <year>2016</year>;<volume>44</volume>(<issue>2</issue>):<fpage>355</fpage>–<lpage>61</lpage>. Epub 2015/12/10. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1177/0363546515616237" xlink:type="simple">10.1177/0363546515616237</ext-link></comment> <object-id pub-id-type="pmid">26646514</object-id>.</mixed-citation></ref>
<ref id="pone.0301194.ref046"><label>46</label><mixed-citation publication-type="journal" xlink:type="simple"><name><surname>Powers</surname> <given-names>CM</given-names></name>, <name><surname>Ghoddosi</surname> <given-names>N</given-names></name>, <name><surname>Straub</surname> <given-names>RK</given-names></name>, <name><surname>Khayambashi</surname> <given-names>K</given-names></name>. <article-title>Hip Strength as a Predictor of Ankle Sprains in Male Soccer Players: A Prospective Study</article-title>. <source>J Athl Train</source>. <year>2017</year>;<volume>52</volume>(<issue>11</issue>):<fpage>1048</fpage>–<lpage>55</lpage>. Epub 2017/11/09. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.4085/1062-6050-52.11.18" xlink:type="simple">10.4085/1062-6050-52.11.18</ext-link></comment> <object-id pub-id-type="pmid">29116830</object-id>.</mixed-citation></ref>
<ref id="pone.0301194.ref047"><label>47</label><mixed-citation publication-type="journal" xlink:type="simple"><name><surname>Mucha</surname> <given-names>MD</given-names></name>, <name><surname>Caldwell</surname> <given-names>W</given-names></name>, <name><surname>Schlueter</surname> <given-names>EL</given-names></name>, <name><surname>Walters</surname> <given-names>C</given-names></name>, <name><surname>Hassen</surname> <given-names>A</given-names></name>. <article-title>Hip abductor strength and lower extremity running related injury in distance runners: A systematic review</article-title>. <source>J Sci Med Sport</source>. <year>2017</year>;<volume>20</volume>(<issue>4</issue>):<fpage>349</fpage>–<lpage>55</lpage>. Epub 2016/10/04. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1016/j.jsams.2016.09.002" xlink:type="simple">10.1016/j.jsams.2016.09.002</ext-link></comment> <object-id pub-id-type="pmid">27693442</object-id>.</mixed-citation></ref>
<ref id="pone.0301194.ref048"><label>48</label><mixed-citation publication-type="journal" xlink:type="simple"><name><surname>Mayne</surname> <given-names>E</given-names></name>, <name><surname>Memarzadeh</surname> <given-names>A</given-names></name>, <name><surname>Raut</surname> <given-names>P</given-names></name>, <name><surname>Arora</surname> <given-names>A</given-names></name>, <name><surname>Khanduja</surname> <given-names>V</given-names></name>. <article-title>Measuring hip muscle strength in patients with femoroacetabular impingement and other hip pathologies: A systematic review</article-title>. <source>Bone Joint Res</source>. <year>2017</year>;<volume>6</volume>(<issue>1</issue>):<fpage>66</fpage>–<lpage>72</lpage>. Epub 2017/01/22. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1302/2046-3758.61.BJR-2016-0081" xlink:type="simple">10.1302/2046-3758.61.BJR-2016-0081</ext-link></comment> <object-id pub-id-type="pmid">28108483</object-id>.</mixed-citation></ref>
<ref id="pone.0301194.ref049"><label>49</label><mixed-citation publication-type="journal" xlink:type="simple"><name><surname>Thorborg</surname> <given-names>K</given-names></name>, <name><surname>Bandholm</surname> <given-names>T</given-names></name>, <name><surname>Holmich</surname> <given-names>P</given-names></name>. <article-title>Hip- and knee-strength assessments using a hand-held dynamometer with external belt-fixation are inter-tester reliable</article-title>. <source>Knee Surg Sports Traumatol Arthrosc</source>. <year>2013</year>;<volume>21</volume>(<issue>3</issue>):<fpage>550</fpage>–<lpage>5</lpage>. Epub 2012/07/10. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1007/s00167-012-2115-2" xlink:type="simple">10.1007/s00167-012-2115-2</ext-link></comment> <object-id pub-id-type="pmid">22773065</object-id>.</mixed-citation></ref>
<ref id="pone.0301194.ref050"><label>50</label><mixed-citation publication-type="journal" xlink:type="simple"><name><surname>Meldrum</surname> <given-names>D</given-names></name>, <name><surname>Cahalane</surname> <given-names>E</given-names></name>, <name><surname>Conroy</surname> <given-names>R</given-names></name>, <name><surname>Fitzgerald</surname> <given-names>D</given-names></name>, <name><surname>Hardiman</surname> <given-names>O</given-names></name>. <article-title>Maximum voluntary isometric contraction: reference values and clinical application</article-title>. <source>Amyotroph Lateral Scler</source>. <year>2007</year>;<volume>8</volume>(<issue>1</issue>):<fpage>47</fpage>–<lpage>55</lpage>. Epub 2007/03/17. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1080/17482960601012491" xlink:type="simple">10.1080/17482960601012491</ext-link></comment> <object-id pub-id-type="pmid">17364436</object-id>.</mixed-citation></ref>
<ref id="pone.0301194.ref051"><label>51</label><mixed-citation publication-type="journal" xlink:type="simple"><name><surname>de Vet</surname> <given-names>HC</given-names></name>, <name><surname>Terwee</surname> <given-names>CB</given-names></name>, <name><surname>Ostelo</surname> <given-names>RW</given-names></name>, <name><surname>Beckerman</surname> <given-names>H</given-names></name>, <name><surname>Knol</surname> <given-names>DL</given-names></name>, <name><surname>Bouter</surname> <given-names>LM</given-names></name>. <article-title>Minimal changes in health status questionnaires: distinction between minimally detectable change and minimally important change</article-title>. <source>Health Qual Life Outcomes</source>. <year>2006</year>;<volume>4</volume>:<fpage>54</fpage>. Epub 2006/08/24. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1186/1477-7525-4-54" xlink:type="simple">10.1186/1477-7525-4-54</ext-link></comment> <object-id pub-id-type="pmid">16925807</object-id>.</mixed-citation></ref>
<ref id="pone.0301194.ref052"><label>52</label><mixed-citation publication-type="journal" xlink:type="simple"><name><surname>Thorborg</surname> <given-names>K</given-names></name>, <name><surname>Petersen</surname> <given-names>J</given-names></name>, <name><surname>Magnusson</surname> <given-names>SP</given-names></name>, <name><surname>Holmich</surname> <given-names>P</given-names></name>. <article-title>Clinical assessment of hip strength using a hand-held dynamometer is reliable</article-title>. <source>Scand J Med Sci Sports</source>. <year>2010</year>;<volume>20</volume>(<issue>3</issue>):<fpage>493</fpage>–<lpage>501</lpage>. Epub 2009/06/30. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1111/j.1600-0838.2009.00958.x" xlink:type="simple">10.1111/j.1600-0838.2009.00958.x</ext-link></comment> <object-id pub-id-type="pmid">19558384</object-id>.</mixed-citation></ref>
<ref id="pone.0301194.ref053"><label>53</label><mixed-citation publication-type="journal" xlink:type="simple"><name><surname>Gribble</surname> <given-names>PA</given-names></name>, <name><surname>Kelly</surname> <given-names>SE</given-names></name>, <name><surname>Refshauge</surname> <given-names>KM</given-names></name>, <name><surname>Hiller</surname> <given-names>CE</given-names></name>. <article-title>Interrater reliability of the star excursion balance test</article-title>. <source>J Athl Train</source>. <year>2013</year>;<volume>48</volume>(<issue>5</issue>):<fpage>621</fpage>–<lpage>6</lpage>. Epub 2013/09/27. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.4085/1062-6050-48.3.03" xlink:type="simple">10.4085/1062-6050-48.3.03</ext-link></comment> <object-id pub-id-type="pmid">24067151</object-id>.</mixed-citation></ref>
<ref id="pone.0301194.ref054"><label>54</label><mixed-citation publication-type="journal" xlink:type="simple"><name><surname>Johansson</surname> <given-names>AC</given-names></name>, <name><surname>Karlsson</surname> <given-names>H</given-names></name>. <article-title>The Star Excursion Balance Test: Criterion and divergent validity on patients with femoral acetabular impingement</article-title>. <source>Man Ther</source>. <year>2016</year>;<volume>26</volume>:<fpage>104</fpage>–<lpage>9</lpage>. Epub 2016/10/31. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1016/j.math.2016.07.015" xlink:type="simple">10.1016/j.math.2016.07.015</ext-link></comment> <object-id pub-id-type="pmid">27525357</object-id>.</mixed-citation></ref>
<ref id="pone.0301194.ref055"><label>55</label><mixed-citation publication-type="journal" xlink:type="simple"><name><surname>Freke</surname> <given-names>M</given-names></name>, <name><surname>Kemp</surname> <given-names>J</given-names></name>, <name><surname>Semciw</surname> <given-names>A</given-names></name>, <name><surname>Sims</surname> <given-names>K</given-names></name>, <name><surname>Russell</surname> <given-names>T</given-names></name>, <name><surname>Singh</surname> <given-names>P</given-names></name>, <etal>et al</etal>. <article-title>Hip Strength and Range of Movement Are Associated With Dynamic Postural Control Performance in Individuals Scheduled for Arthroscopic Hip Surgery</article-title>. <source>J Orthop Sports Phys Ther</source>. <year>2018</year>;<volume>48</volume>(<issue>4</issue>):<fpage>280</fpage>–<lpage>8</lpage>. Epub 2018/04/03. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.2519/jospt.2018.7946" xlink:type="simple">10.2519/jospt.2018.7946</ext-link></comment> <object-id pub-id-type="pmid">29607762</object-id>.</mixed-citation></ref>
<ref id="pone.0301194.ref056"><label>56</label><mixed-citation publication-type="journal" xlink:type="simple"><name><surname>Clohisy</surname> <given-names>JC</given-names></name>, <name><surname>Knaus</surname> <given-names>ER</given-names></name>, <name><surname>Hunt</surname> <given-names>DM</given-names></name>, <name><surname>Lesher</surname> <given-names>JM</given-names></name>, <name><surname>Harris-Hayes</surname> <given-names>M</given-names></name>, <name><surname>Prather</surname> <given-names>H</given-names></name>. <article-title>Clinical presentation of patients with symptomatic anterior hip impingement</article-title>. <source>Clin Orthop Relat Res</source>. <year>2009</year>;<volume>467</volume>(<issue>3</issue>):<fpage>638</fpage>–<lpage>44</lpage>. Epub 2009/01/09. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1007/s11999-008-0680-y" xlink:type="simple">10.1007/s11999-008-0680-y</ext-link></comment> <object-id pub-id-type="pmid">19130160</object-id>.</mixed-citation></ref>
<ref id="pone.0301194.ref057"><label>57</label><mixed-citation publication-type="journal" xlink:type="simple"><name><surname>Cleeland</surname> <given-names>CS</given-names></name>, <name><surname>Ryan</surname> <given-names>KM</given-names></name>. <article-title>Pain assessment: global use of the Brief Pain Inventory</article-title>. <source>Ann Acad Med Singap</source>. <year>1994</year>;<volume>23</volume>(<issue>2</issue>):<fpage>129</fpage>–<lpage>38</lpage>. Epub 1994/03/01. <object-id pub-id-type="pmid">8080219</object-id>.</mixed-citation></ref>
<ref id="pone.0301194.ref058"><label>58</label><mixed-citation publication-type="journal" xlink:type="simple"><name><surname>Turk</surname> <given-names>DC</given-names></name>, <name><surname>Dworkin</surname> <given-names>RH</given-names></name>, <name><surname>McDermott</surname> <given-names>MP</given-names></name>, <name><surname>Bellamy</surname> <given-names>N</given-names></name>, <name><surname>Burke</surname> <given-names>LB</given-names></name>, <name><surname>Chandler</surname> <given-names>JM</given-names></name>, <etal>et al</etal>. <article-title>Analyzing multiple endpoints in clinical trials of pain treatments: IMMPACT recommendations. Initiative on Methods, Measurement, and Pain Assessment in Clinical Trials</article-title>. <source>Pain</source>. <year>2008</year>;<volume>139</volume>(<issue>3</issue>):<fpage>485</fpage>–<lpage>93</lpage>. Epub 2008/08/19. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1016/j.pain.2008.06.025" xlink:type="simple">10.1016/j.pain.2008.06.025</ext-link></comment> <object-id pub-id-type="pmid">18706763</object-id>.</mixed-citation></ref>
<ref id="pone.0301194.ref059"><label>59</label><mixed-citation publication-type="journal" xlink:type="simple"><name><surname>Lindback</surname> <given-names>Y</given-names></name>, <name><surname>Tropp</surname> <given-names>H</given-names></name>, <name><surname>Enthoven</surname> <given-names>P</given-names></name>, <name><surname>Abbott</surname> <given-names>A</given-names></name>, <name><surname>Oberg</surname> <given-names>B</given-names></name>. <article-title>PREPARE: Pre-surgery physiotherapy for patients with degenerative lumbar spine disorder: a randomized controlled trial protocol</article-title>. <source>BMC Musculoskelet Disord</source>. <year>2016</year>;<volume>17</volume>:<fpage>270</fpage>. Epub 2016/07/13. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1186/s12891-016-1126-4" xlink:type="simple">10.1186/s12891-016-1126-4</ext-link></comment> <object-id pub-id-type="pmid">27400960</object-id>.</mixed-citation></ref>
<ref id="pone.0301194.ref060"><label>60</label><mixed-citation publication-type="journal" xlink:type="simple"><name><surname>Parker</surname> <given-names>PA</given-names></name>, <name><surname>Pettaway</surname> <given-names>CA</given-names></name>, <name><surname>Babaian</surname> <given-names>RJ</given-names></name>, <name><surname>Pisters</surname> <given-names>LL</given-names></name>, <name><surname>Miles</surname> <given-names>B</given-names></name>, <name><surname>Fortier</surname> <given-names>A</given-names></name>, <etal>et al</etal>. <article-title>The effects of a presurgical stress management intervention for men with prostate cancer undergoing radical prostatectomy</article-title>. <source>J Clin Oncol</source>. <year>2009</year>;<volume>27</volume>(<issue>19</issue>):<fpage>3169</fpage>–<lpage>76</lpage>. Epub 2009/04/08. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1200/JCO.2007.16.0036" xlink:type="simple">10.1200/JCO.2007.16.0036</ext-link></comment> <object-id pub-id-type="pmid">19349551</object-id>.</mixed-citation></ref>
<ref id="pone.0301194.ref061"><label>61</label><mixed-citation publication-type="journal" xlink:type="simple"><name><surname>Zigmond</surname> <given-names>AS</given-names></name>, <name><surname>Snaith</surname> <given-names>RP</given-names></name>. <article-title>The hospital anxiety and depression scale</article-title>. <source>Acta Psychiatr Scand</source>. <year>1983</year>;<volume>67</volume>(<issue>6</issue>):<fpage>361</fpage>–<lpage>70</lpage>. Epub 1983/06/01. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1111/j.1600-0447.1983.tb09716.x" xlink:type="simple">10.1111/j.1600-0447.1983.tb09716.x</ext-link></comment> <object-id pub-id-type="pmid">6880820</object-id>.</mixed-citation></ref>
<ref id="pone.0301194.ref062"><label>62</label><mixed-citation publication-type="journal" xlink:type="simple"><name><surname>Bjelland</surname> <given-names>I</given-names></name>, <name><surname>Dahl</surname> <given-names>AA</given-names></name>, <name><surname>Haug</surname> <given-names>TT</given-names></name>, <name><surname>Neckelmann</surname> <given-names>D</given-names></name>. <article-title>The validity of the Hospital Anxiety and Depression Scale. An updated literature review</article-title>. <source>J Psychosom Res</source>. <year>2002</year>;<volume>52</volume>(<issue>2</issue>):<fpage>69</fpage>–<lpage>77</lpage>. Epub 2002/02/08. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1016/s0022-3999%2801%2900296-3" xlink:type="simple">10.1016/s0022-3999(01)00296-3</ext-link></comment> <object-id pub-id-type="pmid">11832252</object-id>.</mixed-citation></ref>
<ref id="pone.0301194.ref063"><label>63</label><mixed-citation publication-type="journal" xlink:type="simple"><name><surname>Kamper</surname> <given-names>S</given-names></name>. <article-title>Global Rating of Change scales</article-title>. <source>Aust J Physiother</source>. <year>2009</year>;<volume>55</volume>(<issue>4</issue>):<fpage>289</fpage>. Epub 2009/11/26. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1016/s0004-9514%2809%2970015-7" xlink:type="simple">10.1016/s0004-9514(09)70015-7</ext-link></comment> <object-id pub-id-type="pmid">19929778</object-id>.</mixed-citation></ref>
<ref id="pone.0301194.ref064"><label>64</label><mixed-citation publication-type="journal" xlink:type="simple"><name><surname>Dworkin</surname> <given-names>RH</given-names></name>, <name><surname>Turk</surname> <given-names>DC</given-names></name>, <name><surname>Wyrwich</surname> <given-names>KW</given-names></name>, <name><surname>Beaton</surname> <given-names>D</given-names></name>, <name><surname>Cleeland</surname> <given-names>CS</given-names></name>, <name><surname>Farrar</surname> <given-names>JT</given-names></name>, <etal>et al</etal>. <article-title>Interpreting the clinical importance of treatment outcomes in chronic pain clinical trials: IMMPACT recommendations</article-title>. <source>J Pain</source>. <year>2008</year>;<volume>9</volume>(<issue>2</issue>):<fpage>105</fpage>–<lpage>21</lpage>. Epub 2007/12/07. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1016/j.jpain.2007.09.005" xlink:type="simple">10.1016/j.jpain.2007.09.005</ext-link></comment> <object-id pub-id-type="pmid">18055266</object-id>.</mixed-citation></ref>
<ref id="pone.0301194.ref065"><label>65</label><mixed-citation publication-type="journal" xlink:type="simple"><name><surname>Lancaster</surname> <given-names>GA</given-names></name>, <name><surname>Dodd</surname> <given-names>S</given-names></name>, <name><surname>Williamson</surname> <given-names>PR</given-names></name>. <article-title>Design and analysis of pilot studies: recommendations for good practice</article-title>. <source>J Eval Clin Pract</source>. <year>2004</year>;<volume>10</volume>(<issue>2</issue>):<fpage>307</fpage>–<lpage>12</lpage>. Epub 2004/06/11. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1111/j..2002.384.doc.x" xlink:type="simple">10.1111/j..2002.384.doc.x</ext-link></comment> <object-id pub-id-type="pmid">15189396</object-id>.</mixed-citation></ref>
<ref id="pone.0301194.ref066"><label>66</label><mixed-citation publication-type="other" xlink:type="simple">Sim J, Lewis M. The size of a pilot study for a clinical trial should be calculated in relation to considerations of precision and efficiency. (1878–5921 (Electronic)).</mixed-citation></ref>
<ref id="pone.0301194.ref067"><label>67</label><mixed-citation publication-type="journal" xlink:type="simple"><name><surname>Julious</surname> <given-names>SA</given-names></name>. <article-title>Sample size of 12 per group rule of thumb for a pilot study</article-title>. <source>Pharmaceutical Statistics</source>. <year>2005</year>;<volume>4</volume>(<issue>4</issue>):<fpage>287</fpage>–<lpage>91</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1002/pst.185" xlink:type="simple">10.1002/pst.185</ext-link></comment></mixed-citation></ref>
<ref id="pone.0301194.ref068"><label>68</label><mixed-citation publication-type="other" xlink:type="simple">Terwee CB, Bot Sd Fau—de Boer MR, de Boer Mr Fau—van der Windt DAWM, van der Windt Da Fau—Knol DL, Knol Dl Fau—Dekker J, Dekker J Fau—Bouter LM, et al. Quality criteria were proposed for measurement properties of health status questionnaires. (0895–4356 (Print)).</mixed-citation></ref>
<ref id="pone.0301194.ref069"><label>69</label><mixed-citation publication-type="journal" xlink:type="simple"><name><surname>Schulz</surname> <given-names>KF</given-names></name>, <name><surname>Altman</surname> <given-names>DG</given-names></name>, <name><surname>Moher</surname> <given-names>D</given-names></name>. <article-title>CONSORT 2010 statement: Updated guidelines for reporting parallel group randomised trials</article-title>. <source>J Pharmacol Pharmacother</source>. <year>2010</year>;<volume>1</volume>(<issue>2</issue>):<fpage>100</fpage>–<lpage>7</lpage>. Epub 2011/02/26. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.4103/0976-500X.72352" xlink:type="simple">10.4103/0976-500X.72352</ext-link></comment> <object-id pub-id-type="pmid">21350618</object-id>.</mixed-citation></ref>
<ref id="pone.0301194.ref070"><label>70</label><mixed-citation publication-type="journal" xlink:type="simple"><name><surname>Brett</surname> <given-names>J</given-names></name>, <name><surname>Staniszewska</surname> <given-names>S</given-names></name>, <name><surname>Mockford</surname> <given-names>C</given-names></name>, <name><surname>Herron-Marx</surname> <given-names>S</given-names></name>, <name><surname>Hughes</surname> <given-names>J</given-names></name>, <name><surname>Tysall</surname> <given-names>C</given-names></name>, <etal>et al</etal>. <article-title>Mapping the impact of patient and public involvement on health and social care research: a systematic review</article-title>. <source>Health Expect</source>. <year>2014</year>;<volume>17</volume>(<issue>5</issue>):<fpage>637</fpage>–<lpage>50</lpage>. Epub 2012/07/20. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1111/j.1369-7625.2012.00795.x" xlink:type="simple">10.1111/j.1369-7625.2012.00795.x</ext-link></comment> <object-id pub-id-type="pmid">22809132</object-id>.</mixed-citation></ref>
<ref id="pone.0301194.ref071"><label>71</label><mixed-citation publication-type="book" xlink:type="simple"><name><surname>Bloor</surname> <given-names>M</given-names></name>. <source>Focus groups in social research</source>: <publisher-name>Sage</publisher-name>; <year>2001</year>.</mixed-citation></ref>
<ref id="pone.0301194.ref072"><label>72</label><mixed-citation publication-type="journal" xlink:type="simple"><name><surname>Braun</surname> <given-names>V</given-names></name>, <name><surname>Clarke</surname> <given-names>V</given-names></name>. <article-title>Using thematic analysis in psychology</article-title>. <source>Qualitative Research in Psychology</source>. <year>2006</year>;<volume>3</volume>(<issue>2</issue>):<fpage>77</fpage>–<lpage>101</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1191/1478088706qp063oa" xlink:type="simple">10.1191/1478088706qp063oa</ext-link></comment></mixed-citation></ref>
<ref id="pone.0301194.ref073"><label>73</label><mixed-citation publication-type="journal" xlink:type="simple"><name><surname>Guba</surname> <given-names>EG</given-names></name>. <article-title>ERIC/ECTJ Annual Review Paper: Criteria for Assessing the Trustworthiness of Naturalistic Inquiries</article-title>. <source>Educational Communication and Technology</source>. <year>1981</year>;<volume>29</volume>(<issue>2</issue>):<fpage>75</fpage>–<lpage>91</lpage>.</mixed-citation></ref>
<ref id="pone.0301194.ref074"><label>74</label><mixed-citation publication-type="journal" xlink:type="simple"><name><surname>Welsh</surname> <given-names>E</given-names></name>. <article-title>Dealing with Data: Using NVivo in the Qualitative Data Analysis Process</article-title>. <source>Forum: Qualitative Social Research</source>. <year>2002</year>;<volume>3</volume>.</mixed-citation></ref>
<ref id="pone.0301194.ref075"><label>75</label><mixed-citation publication-type="journal" xlink:type="simple"><name><surname>Hildebrand</surname> <given-names>MW</given-names></name>, <name><surname>Host</surname> <given-names>HH</given-names></name>, <name><surname>Binder</surname> <given-names>EF</given-names></name>, <name><surname>Carpenter</surname> <given-names>B</given-names></name>, <name><surname>Freedland</surname> <given-names>KE</given-names></name>, <name><surname>Morrow-Howell</surname> <given-names>N</given-names></name>, <etal>et al</etal>. <article-title>Measuring treatment fidelity in a rehabilitation intervention study</article-title>. <source>Am J Phys Med Rehabil</source>. <year>2012</year>;<volume>91</volume>(<issue>8</issue>):<fpage>715</fpage>–<lpage>24</lpage>. Epub 2012/03/02. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1097/PHM.0b013e31824ad462" xlink:type="simple">10.1097/PHM.0b013e31824ad462</ext-link></comment> <object-id pub-id-type="pmid">22377824</object-id>.</mixed-citation></ref>
<ref id="pone.0301194.ref076"><label>76</label><mixed-citation publication-type="journal" xlink:type="simple"><name><surname>Toomey</surname> <given-names>E</given-names></name>, <name><surname>Hardeman</surname> <given-names>W</given-names></name>, <name><surname>Hankonen</surname> <given-names>N</given-names></name>, <name><surname>Byrne</surname> <given-names>M</given-names></name>, <name><surname>McSharry</surname> <given-names>J</given-names></name>, <name><surname>Matvienko-Sikar</surname> <given-names>K</given-names></name>, <etal>et al</etal>. <article-title>Focusing on fidelity: narrative review and recommendations for improving intervention fidelity within trials of health behaviour change interventions</article-title>. <source>Health Psychology and Behavioral Medicine</source>. <year>2020</year>;<volume>8</volume>(<issue>1</issue>):<fpage>132</fpage>–<lpage>51</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1080/21642850.2020.1738935" xlink:type="simple">10.1080/21642850.2020.1738935</ext-link></comment> <object-id pub-id-type="pmid">34040865</object-id></mixed-citation></ref>
<ref id="pone.0301194.ref077"><label>77</label><mixed-citation publication-type="journal" xlink:type="simple"><name><surname>Borrelli</surname> <given-names>B</given-names></name>. <article-title>The assessment, monitoring, and enhancement of treatment fidelity in public health clinical trials</article-title>. <source>J Public Health Dent</source>. <year>2011</year>;<volume>71</volume> <issue>Suppl 1</issue>:<fpage>S52</fpage>–<lpage>63</lpage>. Epub 2011/06/10. <object-id pub-id-type="pmid">21656954</object-id>.</mixed-citation></ref>
<ref id="pone.0301194.ref078"><label>78</label><mixed-citation publication-type="other" xlink:type="simple">EDGE: Research Management in Real Time. <ext-link ext-link-type="uri" xlink:href="https://edgeclinical.com" xlink:type="simple">https://edgeclinical.com</ext-link>.</mixed-citation></ref>
<ref id="pone.0301194.ref079"><label>79</label><mixed-citation publication-type="journal" xlink:type="simple"><name><surname>Staniszewska</surname> <given-names>S</given-names></name>, <name><surname>Brett</surname> <given-names>J</given-names></name>, <name><surname>Simera</surname> <given-names>I</given-names></name>, <name><surname>Seers</surname> <given-names>K</given-names></name>, <name><surname>Mockford</surname> <given-names>C</given-names></name>, <name><surname>Goodlad</surname> <given-names>S</given-names></name>, <etal>et al</etal>. <article-title>GRIPP2 reporting checklists: tools to improve reporting of patient and public involvement in research</article-title>. <source>Res Involv Engagem</source>. <year>2017</year>;<volume>3</volume>:<fpage>13</fpage>. Epub 2017/10/25. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1186/s40900-017-0062-2" xlink:type="simple">10.1186/s40900-017-0062-2</ext-link></comment> <object-id pub-id-type="pmid">29062538</object-id>.</mixed-citation></ref>
<ref id="pone.0301194.ref080"><label>80</label><mixed-citation publication-type="journal" xlink:type="simple"><name><surname>Diamond</surname> <given-names>LE</given-names></name>, <name><surname>Dobson</surname> <given-names>FL</given-names></name>, <name><surname>Bennell</surname> <given-names>KL</given-names></name>, <name><surname>Wrigley</surname> <given-names>TV</given-names></name>, <name><surname>Hodges</surname> <given-names>PW</given-names></name>, <name><surname>Hinman</surname> <given-names>RS</given-names></name>. <article-title>Physical impairments and activity limitations in people with femoroacetabular impingement: a systematic review</article-title>. <source>Br J Sports Med</source>. <year>2015</year>;<volume>49</volume>(<issue>4</issue>):<fpage>230</fpage>–<lpage>42</lpage>. Epub 2014/09/24. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1136/bjsports-2013-093340" xlink:type="simple">10.1136/bjsports-2013-093340</ext-link></comment> <object-id pub-id-type="pmid">25246442</object-id>.</mixed-citation></ref>
<ref id="pone.0301194.ref081"><label>81</label><mixed-citation publication-type="journal" xlink:type="simple"><name><surname>Uimonen</surname> <given-names>M</given-names></name>, <name><surname>Kuitunen</surname> <given-names>I</given-names></name>, <name><surname>Paloneva</surname> <given-names>J</given-names></name>, <name><surname>Launonen</surname> <given-names>AP</given-names></name>, <name><surname>Ponkilainen</surname> <given-names>V</given-names></name>, <name><surname>Mattila</surname> <given-names>VM</given-names></name>. <article-title>The impact of the COVID-19 pandemic on waiting times for elective surgery patients: A multicenter study</article-title>. <source>PLoS One</source>. <year>2021</year>;<volume>16</volume>(<issue>7</issue>):<fpage>e0253875</fpage>. Epub 2021/07/07. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1371/journal.pone.0253875" xlink:type="simple">10.1371/journal.pone.0253875</ext-link></comment> <object-id pub-id-type="pmid">34228727</object-id>.</mixed-citation></ref>
<ref id="pone.0301194.ref082"><label>82</label><mixed-citation publication-type="other" xlink:type="simple">Silver JK. Prehabilitation May Help Mitigate an Increase in COVID-19 Peripandemic Surgical Morbidity and Mortality. (1537–7385 (Electronic)).</mixed-citation></ref>
</ref-list>
</back>
<sub-article article-type="aggregated-review-documents" id="pone.0301194.r001" specific-use="decision-letter">
<front-stub>
<article-id pub-id-type="doi">10.1371/journal.pone.0301194.r001</article-id>
<title-group>
<article-title>Decision Letter 0</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname>Zadro</surname>
<given-names>Joshua Robert</given-names>
</name>
<role>Academic Editor</role>
</contrib>
</contrib-group>
<permissions>
<copyright-year>2024</copyright-year>
<copyright-holder>Joshua Robert Zadro</copyright-holder>
<license xlink:href="http://creativecommons.org/licenses/by/4.0/">
<license-p>This is an open access article distributed under the terms of the <ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0/" xlink:type="simple">Creative Commons Attribution License</ext-link>, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.</license-p>
</license>
</permissions>
<related-object document-id="10.1371/journal.pone.0301194" document-id-type="doi" document-type="article" id="rel-obj001" link-type="peer-reviewed-article"/>
<custom-meta-group>
<custom-meta>
<meta-name>Submission Version</meta-name>
<meta-value>0</meta-value>
</custom-meta>
</custom-meta-group>
</front-stub>
<body>
<p>
<named-content content-type="letter-date">7 Nov 2023</named-content>
</p>
<p><!-- <div> -->PONE-D-23-28781<!-- </div> --><!-- <div> -->PREHAB FAI-Prehabilitation for patients undergoing arthroscopic hip surgery for Femoroacetabular Impingement Syndrome - Protocol for an assessor blinded randomised controlled feasibility study<!-- </div> --><!-- <div> -->PLOS ONE</p>
<p>Dear Dr. Khanduja,</p>
<p>Thank you for submitting your manuscript to PLOS ONE. After careful consideration, we feel that it has merit but does not fully meet PLOS ONE’s publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process.</p>
<p>Please submit your revised manuscript by Dec 22 2023 11:59PM. If you will need more time than this to complete your revisions, please reply to this message or contact the journal office at <email xlink:type="simple">plosone@plos.org</email>. When you're ready to submit your revision, log on to <ext-link ext-link-type="uri" xlink:href="https://www.editorialmanager.com/pone/" xlink:type="simple">https://www.editorialmanager.com/pone/</ext-link> and select the 'Submissions Needing Revision' folder to locate your manuscript file.</p>
<p>Please include the following items when submitting your revised manuscript:<!-- </div> --><list list-type="bullet"> <list-item><p>A rebuttal letter that responds to each point raised by the academic editor and reviewer(s). You should upload this letter as a separate file labeled 'Response to Reviewers'.</p></list-item> <list-item><p>A marked-up copy of your manuscript that highlights changes made to the original version. You should upload this as a separate file labeled 'Revised Manuscript with Track Changes'.</p></list-item> <list-item><p>An unmarked version of your revised paper without tracked changes. You should upload this as a separate file labeled 'Manuscript'.</p></list-item></list></p>
<p>If you would like to make changes to your financial disclosure, please include your updated statement in your cover letter. Guidelines for resubmitting your figure files are available below the reviewer comments at the end of this letter.</p>
<p>If applicable, we recommend that you deposit your laboratory protocols in protocols.io to enhance the reproducibility of your results. Protocols.io assigns your protocol its own identifier (DOI) so that it can be cited independently in the future. For instructions see: <ext-link ext-link-type="uri" xlink:href="https://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols" xlink:type="simple">https://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols</ext-link>. Additionally, PLOS ONE offers an option for publishing peer-reviewed Lab Protocol articles, which describe protocols hosted on protocols.io. Read more information on sharing protocols at <ext-link ext-link-type="uri" xlink:href="https://plos.org/protocols?utm_medium=editorial-email&amp;utm_source=authorletters&amp;utm_campaign=protocols" xlink:type="simple">https://plos.org/protocols?utm_medium=editorial-email&amp;utm_source=authorletters&amp;utm_campaign=protocols</ext-link>.</p>
<p>We look forward to receiving your revised manuscript.</p>
<p>Kind regards,</p>
<p>Joshua Robert Zadro, PhD</p>
<p>Academic Editor</p>
<p>PLOS ONE</p>
<p>Journal Requirements:</p>
<p>When submitting your revision, we need you to address these additional requirements.</p>
<p>1. Please ensure that your manuscript meets PLOS ONE's style requirements, including those for file naming. The PLOS ONE style templates can be found at </p>
<p><ext-link ext-link-type="uri" xlink:href="https://journals.plos.org/plosone/s/file?id=wjVg/PLOSOne_formatting_sample_main_body.pdf" xlink:type="simple">https://journals.plos.org/plosone/s/file?id=wjVg/PLOSOne_formatting_sample_main_body.pdf</ext-link> and </p>
<p><ext-link ext-link-type="uri" xlink:href="https://journals.plos.org/plosone/s/file?id=ba62/PLOSOne_formatting_sample_title_authors_affiliations.pdf" xlink:type="simple">https://journals.plos.org/plosone/s/file?id=ba62/PLOSOne_formatting_sample_title_authors_affiliations.pdf</ext-link></p>
<p>2. We note that the grant information you provided in the ‘Funding Information’ and ‘Financial Disclosure’ sections do not match. </p>
<p>When you resubmit, please ensure that you provide the correct grant numbers for the awards you received for your study in the ‘Funding Information’ section.</p>
<p>3. Thank you for stating the following in the Competing Interests section: </p>
<p>"I have read the journal's policy and the authors of this manuscript have the following competing interests: Dr Khanduja reported being a chief investigator</p>
<p>for the NIHR doctoral fellowship during the conduct of the study; receiving consulting fees from Smith &amp; Nephew</p>
<p>PLC and Arthrex Inc, outside the submitted work; serving as a board member for the UK Non-Arthroplasty Hip</p>
<p>Registry, British Hip Society, European Society of Sports Traumatology, Knee Surgery, and Arthroscopy, and the</p>
<p>International Society of Orthopaedic Surgery and Traumatology; and serving on the editorial boards of the Journal</p>
<p>of Clinical Orthopaedics and Trauma, International Journal of Orthopaedics, International Orthopaedics, and Open</p>
<p>Access Journal of Sports Medicine. No other disclosures were reported."</p>
<p>Please confirm that this does not alter your adherence to all PLOS ONE policies on sharing data and materials, by including the following statement: "This does not alter our adherence to  PLOS ONE policies on sharing data and materials.” (as detailed online in our guide for authors <ext-link ext-link-type="uri" xlink:href="http://journals.plos.org/plosone/s/competing-interests" xlink:type="simple">http://journals.plos.org/plosone/s/competing-interests</ext-link>).  If there are restrictions on sharing of data and/or materials, please state these. Please note that we cannot proceed with consideration of your article until this information has been declared. </p>
<p>Please include your updated Competing Interests statement in your cover letter; we will change the online submission form on your behalf.</p>
<p>4. In your Data Availability statement, you have not specified where the minimal data set underlying the results described in your manuscript can be found. PLOS defines a study's minimal data set as the underlying data used to reach the conclusions drawn in the manuscript and any additional data required to replicate the reported study findings in their entirety. All PLOS journals require that the minimal data set be made fully available. For more information about our data policy, please see <ext-link ext-link-type="uri" xlink:href="http://journals.plos.org/plosone/s/data-availability" xlink:type="simple">http://journals.plos.org/plosone/s/data-availability</ext-link>.</p>
<p>"Upon re-submitting your revised manuscript, please upload your study’s minimal underlying data set as either Supporting Information files or to a stable, public repository and include the relevant URLs, DOIs, or accession numbers within your revised cover letter. For a list of acceptable repositories, please see <ext-link ext-link-type="uri" xlink:href="http://journals.plos.org/plosone/s/data-availability#loc-recommended-repositories" xlink:type="simple">http://journals.plos.org/plosone/s/data-availability#loc-recommended-repositories</ext-link>. Any potentially identifying patient information must be fully anonymized.</p>
<p>Important: If there are ethical or legal restrictions to sharing your data publicly, please explain these restrictions in detail. Please see our guidelines for more information on what we consider unacceptable restrictions to publicly sharing data: <ext-link ext-link-type="uri" xlink:href="http://journals.plos.org/plosone/s/data-availability#loc-unacceptable-data-access-restrictions" xlink:type="simple">http://journals.plos.org/plosone/s/data-availability#loc-unacceptable-data-access-restrictions</ext-link>. Note that it is not acceptable for the authors to be the sole named individuals responsible for ensuring data access.</p>
<p>We will update your Data Availability statement to reflect the information you provide in your cover letter.</p>
<p>5. PLOS requires an ORCID iD for the corresponding author in Editorial Manager on papers submitted after December 6th, 2016. Please ensure that you have an ORCID iD and that it is validated in Editorial Manager. To do this, go to ‘Update my Information’ (in the upper left-hand corner of the main menu), and click on the Fetch/Validate link next to the ORCID field. This will take you to the ORCID site and allow you to create a new iD or authenticate a pre-existing iD in Editorial Manager. Please see the following video for instructions on linking an ORCID iD to your Editorial Manager account: <ext-link ext-link-type="uri" xlink:href="https://www.youtube.com/watch?v=_xcclfuvtxQ" xlink:type="simple">https://www.youtube.com/watch?v=_xcclfuvtxQ</ext-link></p>
<p>6. Your ethics statement should only appear in the Methods section of your manuscript. If your ethics statement is written in any section besides the Methods, please move it to the Methods section and delete it from any other section. Please ensure that your ethics statement is included in your manuscript, as the ethics statement entered into the online submission form will not be published alongside your manuscript. </p>
<p>7. We note that Figure 2 in your submission contain copyrighted images. All PLOS content is published under the Creative Commons Attribution License (CC BY 4.0), which means that the manuscript, images, and Supporting Information files will be freely available online, and any third party is permitted to access, download, copy, distribute, and use these materials in any way, even commercially, with proper attribution. For more information, see our copyright guidelines: <ext-link ext-link-type="uri" xlink:href="http://journals.plos.org/plosone/s/licenses-and-copyright" xlink:type="simple">http://journals.plos.org/plosone/s/licenses-and-copyright</ext-link>.</p>
<p>We require you to either (1) present written permission from the copyright holder to publish these figures specifically under the CC BY 4.0 license, or (2) remove the figures from your submission:</p>
<p>a. You may seek permission from the original copyright holder of Figure 2 to publish the content specifically under the CC BY 4.0 license. </p>
<p>We recommend that you contact the original copyright holder with the Content Permission Form (<ext-link ext-link-type="uri" xlink:href="http://journals.plos.org/plosone/s/file?id=7c09/content-permission-form.pdf" xlink:type="simple">http://journals.plos.org/plosone/s/file?id=7c09/content-permission-form.pdf</ext-link>) and the following text:</p>
<p>“I request permission for the open-access journal PLOS ONE to publish XXX under the Creative Commons Attribution License (CCAL) CC BY 4.0 (<ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0/" xlink:type="simple">http://creativecommons.org/licenses/by/4.0/</ext-link>). Please be aware that this license allows unrestricted use and distribution, even commercially, by third parties. Please reply and provide explicit written permission to publish XXX under a CC BY license and complete the attached form.”</p>
<p>Please upload the completed Content Permission Form or other proof of granted permissions as an "Other" file with your submission. </p>
<p>In the figure caption of the copyrighted figure, please include the following text: “Reprinted from [ref] under a CC BY license, with permission from [name of publisher], original copyright [original copyright year].”</p>
<p>b. If you are unable to obtain permission from the original copyright holder to publish these figures under the CC BY 4.0 license or if the copyright holder’s requirements are incompatible with the CC BY 4.0 license, please either i) remove the figure or ii) supply a replacement figure that complies with the CC BY 4.0 license. Please check copyright information on all replacement figures and update the figure caption with source information. If applicable, please specify in the figure caption text when a figure is similar but not identical to the original image and is therefore for illustrative purposes only.</p>
<p>8. Please include captions for your Supporting Information files at the end of your manuscript, and update any in-text citations to match accordingly. Please see our Supporting Information guidelines for more information: <ext-link ext-link-type="uri" xlink:href="http://journals.plos.org/plosone/s/supporting-information. " xlink:type="simple">http://journals.plos.org/plosone/s/supporting-information. </ext-link></p>
<p>9. We note that S1 File includes an image of a [patient / participant / in the study]. </p>
<p>As per the PLOS ONE policy (<ext-link ext-link-type="uri" xlink:href="http://journals.plos.org/plosone/s/submission-guidelines#loc-human-subjects-research" xlink:type="simple">http://journals.plos.org/plosone/s/submission-guidelines#loc-human-subjects-research</ext-link>) on papers that include identifying, or potentially identifying, information, the individual(s) or parent(s)/guardian(s) must be informed of the terms of the PLOS open-access (CC-BY) license and provide specific permission for publication of these details under the terms of this license. Please download the Consent Form for Publication in a PLOS Journal (<ext-link ext-link-type="uri" xlink:href="http://journals.plos.org/plosone/s/file?id=8ce6/plos-consent-form-english.pdf" xlink:type="simple">http://journals.plos.org/plosone/s/file?id=8ce6/plos-consent-form-english.pdf</ext-link>). The signed consent form should not be submitted with the manuscript, but should be securely filed in the individual's case notes. Please amend the methods section and ethics statement of the manuscript to explicitly state that the patient/participant has provided consent for publication: “The individual in this manuscript has given written informed consent (as outlined in PLOS consent form) to publish these case details”. </p>
<p>If you are unable to obtain consent from the subject of the photograph, you will need to remove the figure and any other textual identifying information or case descriptions for this individual.</p>
<p>Additional Editor Comments:</p>
<p>This is an interesting and important protocol however there are several key issues related to the statistical analysis that need to be addressed (as raised by Reviewer #3).</p>
<p>[Note: HTML markup is below. Please do not edit.]</p>
<p>Reviewers' comments:</p>
<p>Reviewer's Responses to Questions</p>
<p><!-- <font color="black"> --><bold>Comments to the Author</bold></p>
<p>1. Does the manuscript provide a valid rationale for the proposed study, with clearly identified and justified research questions?</p>
<p>The research question outlined is expected to address a valid academic problem or topic and contribute to the base of knowledge in the field.<!-- </font> --></p>
<p>Reviewer #1: Yes</p>
<p>Reviewer #2: Partly</p>
<p>Reviewer #3: Yes</p>
<p>**********</p>
<p><!-- <font color="black"> -->2. Is the protocol technically sound and planned in a manner that will lead to a meaningful outcome and allow testing the stated hypotheses?</p>
<p>The manuscript should describe the methods in sufficient detail to prevent undisclosed flexibility in the experimental procedure or analysis pipeline, including sufficient outcome-neutral conditions (e.g. necessary controls, absence of floor or ceiling effects) to test the proposed hypotheses and a statistical power analysis where applicable. As there may be aspects of the methodology and analysis which can only be refined once the work is undertaken, authors should outline potential assumptions and explicitly describe what aspects of the proposed analyses, if any, are exploratory.<!-- </font> --></p>
<p>Reviewer #1: Yes</p>
<p>Reviewer #2: Partly</p>
<p>Reviewer #3: Partly</p>
<p>**********</p>
<p><!-- <font color="black"> -->3. Is the methodology feasible and described in sufficient detail to allow the work to be replicable?</p>
<p>Descriptions of methods and materials in the protocol should be reported in sufficient detail for another researcher to reproduce all experiments and analyses. The protocol should describe the appropriate controls, sample size calculations, and replication needed to ensure that the data are robust and reproducible.<!-- </font> --></p>
<p>Reviewer #1: Yes</p>
<p>Reviewer #2: Yes</p>
<p>Reviewer #3: No</p>
<p>**********</p>
<p><!-- <font color="black"> -->4. Have the authors described where all data underlying the findings will be made available when the study is complete?</p>
<p>The <ext-link ext-link-type="uri" xlink:href="https://journals.plos.org/plosone/s/materials-and-software-sharing" xlink:type="simple">PLOS Data policy</ext-link> requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception, at the time of publication. The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified.<!-- </font> --></p>
<p>Reviewer #1: Yes</p>
<p>Reviewer #2: Yes</p>
<p>Reviewer #3: No</p>
<p>**********</p>
<p><!-- <font color="black"> -->5. Is the manuscript presented in an intelligible fashion and written in standard English?</p>
<p>PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here.<!-- </font> --></p>
<p>Reviewer #1: Yes</p>
<p>Reviewer #2: No</p>
<p>Reviewer #3: Yes</p>
<p>**********</p>
<p><!-- <font color="black"> -->6. Review Comments to the Author</p>
<p>Please use the space provided to explain your answers to the questions above and, if applicable, provide comments about issues authors must address before this protocol can be accepted for publication. You may also include additional comments for the author, including concerns about research or publication ethics.</p>
<p>You may also provide optional suggestions and comments to authors that they might find helpful in planning their study.</p>
<p>(Please upload your review as an attachment if it exceeds 20,000 characters)<!-- </font> --></p>
<p>Reviewer #1: I thank the author for the opportunity to review this mixed methods study investigating the feasibility of a prehabilitation programme for patients with femoral acetabular impingement syndrome. Overall, the protocol is clear and well written. The introduction could be more specific when discussing surgical and non-surgical management. Some more specific comments are below.</p>
<p>Introduction</p>
<p>88 which outcomes showed significant improvement? And at what time point?</p>
<p>90 Which patient group had improvements? (Surgery vs non surgery results are not clear here when randomised control trials have shown similar function at 24 months between groups)</p>
<p>Participants</p>
<p>Will participants be given the option to have non-surgical management if they see significant improvements with prehabilitation over the 8-week period from their baseline measurements?</p>
<p>Reviewer #2: I would like to congratulate the efforts you have made. However, there are still some improvements could be made for this manuscript:</p>
<p>The introduction should be more specific, supported by evidence, and provide detailed background information to clarify the study's purpose and importance. The evidence should align closely with the research aims.</p>
<p>The strength of this study lies in its evidence-based approach. I suggest that the author organize the evidence more effectively to create a robust evidence statement. Ensure that the evidence provided aligns closely with the study's research aims or objectives.</p>
<p>I recommend that the author refine or rephrase the relevant sentences to ensure a stronger connection between the evidence and the study's purpose.</p>
<p>Consider allocating participants before baseline evaluation to minimize bias and enhance the validity of results.</p>
<p>Please find detailed comments and suggestions for improvement provided below:</p>
<p>Abstract:</p>
<p>I suggest that the author mention what outcome will be measured in the method section for better understanding.</p>
<p>Page 4, lines 74-76</p>
<p>“An epidemiological study conducted in 2015 reported a high prevalence of FAI (47%, 95% CI 42,51), within a sample (n=200, aged 16-65 years) representative of the UK population”. This sentence is a bit hard to follow, maybe try to reword the sentence and emphasize the high prevalence in the UK population with specific values, e.g. “An epidemiological study revealed a high prevalence of FAI, with 47% of the sample ….”. Please notice the correct format of the confidence interval (95%CI: [42-51]).</p>
<p>Page 4, lines 90-92</p>
<p>“However, results from these trials demonstrate that only half (51%) 91 of participants showed significant improvement on the primary outcome measure – iHOT33 (mean difference 6·8 points; 95% CI 1·7–12·0) [10]”. Does ‘these trials’ represent both surgery and physiotherapy? The author mentioned iHOT33 to demonstrate the evidence, but you need to specify what this outcome measured for, i.e., quality of life.</p>
<p>S1 File</p>
<p>The programme is based on the consensus statement as evidence-based practice, the author needs to make sure the reference is cited.</p>
<p>Page 9, lines 187-191</p>
<p>“…after prehabilitation before surgery, and at 6 weeks+/- 4 weeks and 6 months+/- 4 weeks (planned primary endpoint for definitive RCT) postoperatively when participants attend the research site for clinical care. Additionally, all patient-reported outcome measures will be captured at 12 months+/-4 weeks post-op.’’</p>
<p>Are the programme phases designed according to the evidence of systematic review or consensus statement? It is better to bring some evidence to illustrate why this particular timeline (in the introduction section), to strengthen the purpose of this study.</p>
<p>Page 9, line 201: “Chief Investigator (CI)”</p>
<p>The author mentioned confidence interval as CI in the previous Introduction section, but the same abbreviation appears in the Method section. Distinguish between "CI" as Chief Investigator and "CI" as a confidence interval for clarity.</p>
<p>Page 16 Randomization and blinding</p>
<p>“Following baseline evaluation, participants will be randomly allocated to one of the two groups (prehabilitation or usual care) by the PI using a computer-generated simple random allocation sequence.”</p>
<p>If participants are allocated after baseline evaluation, there's a risk that the group assignments could be influenced by the knowledge of individual participants' baseline characteristics, and this could introduce bias into the study. Therefore, I recommend the author consider allocating participants before any baseline evaluations or interventions applied. This approach helps maintain the validity and scientific evidence of the results. Otherwise, you need to justify why the allocation is after the baseline evaluation.</p>
<p>This section needs to make more efforts to improve the study’s transparency and clarity. It is better to rearrange the section's placement for better flow, i.e., put this section before the outcome measurements.</p>
<p>Page 24, lines 543-549</p>
<p>The author needs to improve the description of the study's strengths, focusing on its potential impact on future research and benefits to patients. The author should consider what the outcome could bring to future research, what benefit could bring to the patients who need surgical intervention, and whether qualitative research could have an impact on the participants.</p>
<p>I believe that I have been clear in my suggestions, and I am available for further clarification.</p>
<p>Kindest regard</p>
<p>Reviewer #3: This manuscript is a study protocol of a blinded randomized control trial to assess the feasibility, acceptability and safety of a FAI-prehabilitation program in patients undergoing hip surgery. The trial was registered via a valid ISRCTN number, and was approved by the respective ethics board. The study objectives are on target. However, I mostly have some concerns/comments in the statistical design and analytical framework, and CONSORT guidelines, which may require attention:</p>
<p>1. Randomization: More details are needed in this section, specifically, what does the authors meant by a computer-generated random allocation sequence? Furthermore, why a block randomization (often convenient and appealing in RCTs) not conducted?</p>
<p>2. Sample size/Power: The sample size/power writeup does not present the desired effect size that the investigators want to power the study upon; they only referr to a published paper. More details needed. Furthermore, it doesn't clearly state the specific statistical tests that was used to calculate the power/sample sizes. Moreover, given the apparent longitudinal nature of the study (statistical analysis will assess study outcome measures), sample sizes could have been computed, reflecting the actual study design (repetitions), keeping the same significance level, and same power. ANOVA could be used directly to compute the sample size, versus some simple 2/multiple group tests. Several software provide that option as well. Justification is missing in that regard.</p>
<p>3. Statistical Analysis: Independent t-tests are valid only under Normality assumptions. Alternative statistical methods are not discussed, under violations to the Gaussian assumptions. Furthermore, since the study will be conducted at repeated time-points, it is not clear why a GEE, a mixed model, or even an ANOVA (repeated measures, precisely) was not proposed. Authors might be only interested in evaluating the final endpoint, however, evaluating the trajectory (since data will be available at the intermediate time-points) may strengthen the analysis.</p>
<p>4. Writing style:</p>
<p>Discussion Section: Given the study was designed only for UK subjects, the Discussion section should clearly allude to future studies with other populations and geographical regions to further validate their current findings. Currently, the findings are only limited to this population.</p>
<p>**********</p>
<p><!-- <font color="black"> -->7. PLOS authors have the option to publish the peer review history of their article (<ext-link ext-link-type="uri" xlink:href="https://journals.plos.org/plosone/s/editorial-and-peer-review-process#loc-peer-review-history" xlink:type="simple">what does this mean?</ext-link>). If published, this will include your full peer review and any attached files.</p>
<p>If you choose “no”, your identity will remain anonymous but your review may still be made public.</p>
<p><bold>Do you want your identity to be public for this peer review?</bold> For information about this choice, including consent withdrawal, please see our <ext-link ext-link-type="uri" xlink:href="https://www.plos.org/privacy-policy" xlink:type="simple">Privacy Policy</ext-link>.<!-- </font> --></p>
<p>Reviewer #1: No</p>
<p>Reviewer #2: No</p>
<p>Reviewer #3: No</p>
<p>**********</p>
<p>[NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files.]</p>
<p>While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, <ext-link ext-link-type="uri" xlink:href="https://pacev2.apexcovantage.com/" xlink:type="simple">https://pacev2.apexcovantage.com/</ext-link>. PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Registration is free. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email PLOS at <email xlink:type="simple">figures@plos.org</email>. Please note that Supporting Information files do not need this step.</p>
</body>
</sub-article>
<sub-article article-type="author-comment" id="pone.0301194.r002">
<front-stub>
<article-id pub-id-type="doi">10.1371/journal.pone.0301194.r002</article-id>
<title-group>
<article-title>Author response to Decision Letter 0</article-title>
</title-group>
<related-object document-id="10.1371/journal.pone.0301194" document-id-type="doi" document-type="peer-reviewed-article" id="rel-obj002" link-type="rebutted-decision-letter" object-id="10.1371/journal.pone.0301194.r001" object-id-type="doi" object-type="decision-letter"/>
<custom-meta-group>
<custom-meta>
<meta-name>Submission Version</meta-name>
<meta-value>1</meta-value>
</custom-meta>
</custom-meta-group>
</front-stub>
<body>
<p>
<named-content content-type="author-response-date">5 Feb 2024</named-content>
</p>
<p>The response to the editor and reviewers have been uploaded as a separate document. Please see uploaded documents</p>
<supplementary-material id="pone.0301194.s006" mimetype="application/vnd.openxmlformats-officedocument.wordprocessingml.document" position="float" xlink:href="pone.0301194.s006.docx" xlink:type="simple">
<label>Attachment</label>
<caption>
<p>Submitted filename: <named-content content-type="submitted-filename">PLOS one Rebuttal.docx</named-content></p>
</caption>
</supplementary-material>
</body>
</sub-article>
<sub-article article-type="aggregated-review-documents" id="pone.0301194.r003" specific-use="decision-letter">
<front-stub>
<article-id pub-id-type="doi">10.1371/journal.pone.0301194.r003</article-id>
<title-group>
<article-title>Decision Letter 1</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname>Zadro</surname>
<given-names>Joshua Robert</given-names>
</name>
<role>Academic Editor</role>
</contrib>
</contrib-group>
<permissions>
<copyright-year>2024</copyright-year>
<copyright-holder>Joshua Robert Zadro</copyright-holder>
<license xlink:href="http://creativecommons.org/licenses/by/4.0/">
<license-p>This is an open access article distributed under the terms of the <ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0/" xlink:type="simple">Creative Commons Attribution License</ext-link>, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.</license-p>
</license>
</permissions>
<related-object document-id="10.1371/journal.pone.0301194" document-id-type="doi" document-type="article" id="rel-obj003" link-type="peer-reviewed-article"/>
<custom-meta-group>
<custom-meta>
<meta-name>Submission Version</meta-name>
<meta-value>1</meta-value>
</custom-meta>
</custom-meta-group>
</front-stub>
<body>
<p>
<named-content content-type="letter-date">13 Feb 2024</named-content>
</p>
<p><!-- <div> -->PONE-D-23-28781R1<!-- </div> --><!-- <div> -->PREHAB FAI-Prehabilitation for patients undergoing arthroscopic hip surgery for Femoroacetabular Impingement Syndrome - Protocol for an assessor blinded randomised controlled feasibility study<!-- </div> --><!-- <div> -->PLOS ONE</p>
<p>Dear Dr. Khanduja,</p>
<p>Thank you for submitting your manuscript to PLOS ONE. After careful consideration, we feel that it has merit but does not fully meet PLOS ONE’s publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process.</p>
<p>Please submit your revised manuscript by Mar 29 2024 11:59PM. If you will need more time than this to complete your revisions, please reply to this message or contact the journal office at <email xlink:type="simple">plosone@plos.org</email>. When you're ready to submit your revision, log on to <ext-link ext-link-type="uri" xlink:href="https://www.editorialmanager.com/pone/" xlink:type="simple">https://www.editorialmanager.com/pone/</ext-link> and select the 'Submissions Needing Revision' folder to locate your manuscript file.</p>
<p>Please include the following items when submitting your revised manuscript:<!-- </div> --><list list-type="bullet"><list-item><p>A rebuttal letter that responds to each point raised by the academic editor and reviewer(s). You should upload this letter as a separate file labeled 'Response to Reviewers'.</p></list-item><list-item><p>A marked-up copy of your manuscript that highlights changes made to the original version. You should upload this as a separate file labeled 'Revised Manuscript with Track Changes'.</p></list-item><list-item><p>An unmarked version of your revised paper without tracked changes. You should upload this as a separate file labeled 'Manuscript'.</p></list-item></list><!-- <div> -->If you would like to make changes to your financial disclosure, please include your updated statement in your cover letter. Guidelines for resubmitting your figure files are available below the reviewer comments at the end of this letter.</p>
<p>If applicable, we recommend that you deposit your laboratory protocols in protocols.io to enhance the reproducibility of your results. Protocols.io assigns your protocol its own identifier (DOI) so that it can be cited independently in the future. For instructions see: <ext-link ext-link-type="uri" xlink:href="https://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols" xlink:type="simple">https://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols</ext-link>. Additionally, PLOS ONE offers an option for publishing peer-reviewed Lab Protocol articles, which describe protocols hosted on protocols.io. Read more information on sharing protocols at <ext-link ext-link-type="uri" xlink:href="https://plos.org/protocols?utm_medium=editorial-email&amp;utm_source=authorletters&amp;utm_campaign=protocols" xlink:type="simple">https://plos.org/protocols?utm_medium=editorial-email&amp;utm_source=authorletters&amp;utm_campaign=protocols</ext-link>.</p>
<p>We look forward to receiving your revised manuscript.</p>
<p>Kind regards,</p>
<p>Joshua Robert Zadro, PhD</p>
<p>Academic Editor</p>
<p>PLOS ONE</p>
<p>Journal Requirements:</p>
<p>Please review your reference list to ensure that it is complete and correct. If you have cited papers that have been retracted, please include the rationale for doing so in the manuscript text, or remove these references and replace them with relevant current references. Any changes to the reference list should be mentioned in the rebuttal letter that accompanies your revised manuscript. If you need to cite a retracted article, indicate the article’s retracted status in the References list and also include a citation and full reference for the retraction notice.</p>
<p>Additional Editor Comments:</p>
<p>I thank you for addressing the reviewers comments adequately. am happy to accept this manuscript once the additional comment from the statistical editor is addressed.</p>
<p>[Note: HTML markup is below. Please do not edit.]</p>
<p>Reviewers' comments:</p>
<p>Reviewer's Responses to Questions</p>
<p><!-- <font color="black"> --><bold>Comments to the Author</bold></p>
<p>1. Does the manuscript provide a valid rationale for the proposed study, with clearly identified and justified research questions?</p>
<p>The research question outlined is expected to address a valid academic problem or topic and contribute to the base of knowledge in the field.<!-- </font> --></p>
<p>Reviewer #3: Yes</p>
<p>**********</p>
<p><!-- <font color="black"> -->2. Is the protocol technically sound and planned in a manner that will lead to a meaningful outcome and allow testing the stated hypotheses?</p>
<p>The manuscript should describe the methods in sufficient detail to prevent undisclosed flexibility in the experimental procedure or analysis pipeline, including sufficient outcome-neutral conditions (e.g. necessary controls, absence of floor or ceiling effects) to test the proposed hypotheses and a statistical power analysis where applicable. As there may be aspects of the methodology and analysis which can only be refined once the work is undertaken, authors should outline potential assumptions and explicitly describe what aspects of the proposed analyses, if any, are exploratory.<!-- </font> --></p>
<p>Reviewer #3: Yes</p>
<p>**********</p>
<p><!-- <font color="black"> -->3. Is the methodology feasible and described in sufficient detail to allow the work to be replicable?</p>
<p>Descriptions of methods and materials in the protocol should be reported in sufficient detail for another researcher to reproduce all experiments and analyses. The protocol should describe the appropriate controls, sample size calculations, and replication needed to ensure that the data are robust and reproducible.<!-- </font> --></p>
<p>Reviewer #3: Yes</p>
<p>**********</p>
<p><!-- <font color="black"> -->4. Have the authors described where all data underlying the findings will be made available when the study is complete?</p>
<p>The <ext-link ext-link-type="uri" xlink:href="https://journals.plos.org/plosone/s/materials-and-software-sharing" xlink:type="simple">PLOS Data policy</ext-link> requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception, at the time of publication. The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified.<!-- </font> --></p>
<p>Reviewer #3: Yes</p>
<p>**********</p>
<p><!-- <font color="black"> -->5. Is the manuscript presented in an intelligible fashion and written in standard English?</p>
<p>PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here.<!-- </font> --></p>
<p>Reviewer #3: Yes</p>
<p>**********</p>
<p><!-- <font color="black"> -->6. Review Comments to the Author</p>
<p>Please use the space provided to explain your answers to the questions above and, if applicable, provide comments about issues authors must address before this protocol can be accepted for publication. You may also include additional comments for the author, including concerns about research or publication ethics.</p>
<p>You may also provide optional suggestions and comments to authors that they might find helpful in planning their study.</p>
<p>(Please upload your review as an attachment if it exceeds 20,000 characters)<!-- </font> --></p>
<p>Reviewer #3: The authors were able to address my previous comments with a great degree of satisfaction. However, I would still recommend a statement of sample size, given that feasibility trials also require a guideline wrt. sample sizes. Otherwise, I would not consider the manuscript to be full-proof.</p>
<p>**********</p>
<p><!-- <font color="black"> -->7. PLOS authors have the option to publish the peer review history of their article (<ext-link ext-link-type="uri" xlink:href="https://journals.plos.org/plosone/s/editorial-and-peer-review-process#loc-peer-review-history" xlink:type="simple">what does this mean?</ext-link>). If published, this will include your full peer review and any attached files.</p>
<p>If you choose “no”, your identity will remain anonymous but your review may still be made public.</p>
<p><bold>Do you want your identity to be public for this peer review?</bold> For information about this choice, including consent withdrawal, please see our <ext-link ext-link-type="uri" xlink:href="https://www.plos.org/privacy-policy" xlink:type="simple">Privacy Policy</ext-link>.<!-- </font> --></p>
<p>Reviewer #3: No</p>
<p>**********</p>
<p>[NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files.]</p>
<p>While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, <ext-link ext-link-type="uri" xlink:href="https://pacev2.apexcovantage.com/" xlink:type="simple">https://pacev2.apexcovantage.com/</ext-link>. PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Registration is free. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email PLOS at <email xlink:type="simple">figures@plos.org</email>. Please note that Supporting Information files do not need this step.</p>
</body>
</sub-article>
<sub-article article-type="author-comment" id="pone.0301194.r004">
<front-stub>
<article-id pub-id-type="doi">10.1371/journal.pone.0301194.r004</article-id>
<title-group>
<article-title>Author response to Decision Letter 1</article-title>
</title-group>
<related-object document-id="10.1371/journal.pone.0301194" document-id-type="doi" document-type="peer-reviewed-article" id="rel-obj004" link-type="rebutted-decision-letter" object-id="10.1371/journal.pone.0301194.r003" object-id-type="doi" object-type="decision-letter"/>
<custom-meta-group>
<custom-meta>
<meta-name>Submission Version</meta-name>
<meta-value>2</meta-value>
</custom-meta>
</custom-meta-group>
</front-stub>
<body>
<p>
<named-content content-type="author-response-date">9 Mar 2024</named-content>
</p>
<p>All recommendations have been addressed in the attached rebuttal letter</p>
<supplementary-material id="pone.0301194.s007" mimetype="application/vnd.openxmlformats-officedocument.wordprocessingml.document" position="float" xlink:href="pone.0301194.s007.docx" xlink:type="simple">
<label>Attachment</label>
<caption>
<p>Submitted filename: <named-content content-type="submitted-filename">PLOS one Rebuttal.docx</named-content></p>
</caption>
</supplementary-material>
</body>
</sub-article>
<sub-article article-type="editor-report" id="pone.0301194.r005" specific-use="decision-letter">
<front-stub>
<article-id pub-id-type="doi">10.1371/journal.pone.0301194.r005</article-id>
<title-group>
<article-title>Decision Letter 2</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname>Zadro</surname>
<given-names>Joshua Robert</given-names>
</name>
<role>Academic Editor</role>
</contrib>
</contrib-group>
<permissions>
<copyright-year>2024</copyright-year>
<copyright-holder>Joshua Robert Zadro</copyright-holder>
<license xlink:href="http://creativecommons.org/licenses/by/4.0/">
<license-p>This is an open access article distributed under the terms of the <ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0/" xlink:type="simple">Creative Commons Attribution License</ext-link>, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.</license-p>
</license>
</permissions>
<related-object document-id="10.1371/journal.pone.0301194" document-id-type="doi" document-type="article" id="rel-obj005" link-type="peer-reviewed-article"/>
<custom-meta-group>
<custom-meta>
<meta-name>Submission Version</meta-name>
<meta-value>2</meta-value>
</custom-meta>
</custom-meta-group>
</front-stub>
<body>
<p>
<named-content content-type="letter-date">13 Mar 2024</named-content>
</p>
<p>PREHAB FAI-Prehabilitation for patients undergoing arthroscopic hip surgery for Femoroacetabular Impingement Syndrome - Protocol for an assessor blinded randomised controlled feasibility study</p>
<p>PONE-D-23-28781R2</p>
<p>Dear Dr. Khanduja,</p>
<p>We’re pleased to inform you that your manuscript has been judged scientifically suitable for publication and will be formally accepted for publication once it meets all outstanding technical requirements.</p>
<p>Within one week, you’ll receive an e-mail detailing the required amendments. When these have been addressed, you’ll receive a formal acceptance letter and your manuscript will be scheduled for publication.</p>
<p>An invoice will be generated when your article is formally accepted. Please note, if your institution has a publishing partnership with PLOS and your article meets the relevant criteria, all or part of your publication costs will be covered. Please make sure your user information is up-to-date by logging into Editorial Manager at <ext-link ext-link-type="uri" xlink:href="http://www.editorialmanager.com/pone/" xlink:type="simple">http://www.editorialmanager.com/pone/</ext-link> and clicking the ‘Update My Information' link at the top of the page. If you have any questions relating to publication charges, please contact our Author Billing department directly at <email xlink:type="simple">authorbilling@plos.org</email>.</p>
<p>If your institution or institutions have a press office, please notify them about your upcoming paper to help maximize its impact. If they’ll be preparing press materials, please inform our press team as soon as possible -- no later than 48 hours after receiving the formal acceptance. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information, please contact <email xlink:type="simple">onepress@plos.org</email>.</p>
<p>Kind regards,</p>
<p>Joshua Robert Zadro, PhD</p>
<p>Academic Editor</p>
<p>PLOS ONE</p>
<p>Additional Editor Comments (optional):</p>
<p>I thank the authors for being so attentive to the reviewers comments. I am happy to accept this protocol and wish the authors all the best for conducting the trial.</p>
<p>Reviewers' comments:</p>
</body>
</sub-article>
<sub-article article-type="editor-report" id="pone.0301194.r006" specific-use="acceptance-letter">
<front-stub>
<article-id pub-id-type="doi">10.1371/journal.pone.0301194.r006</article-id>
<title-group>
<article-title>Acceptance letter</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname>Zadro</surname>
<given-names>Joshua Robert</given-names>
</name>
<role>Academic Editor</role>
</contrib>
</contrib-group>
<permissions>
<copyright-year>2024</copyright-year>
<copyright-holder>Joshua Robert Zadro</copyright-holder>
<license xlink:href="http://creativecommons.org/licenses/by/4.0/">
<license-p>This is an open access article distributed under the terms of the <ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0/" xlink:type="simple">Creative Commons Attribution License</ext-link>, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.</license-p>
</license>
</permissions>
<related-object document-id="10.1371/journal.pone.0301194" document-id-type="doi" document-type="article" id="rel-obj006" link-type="peer-reviewed-article"/>
</front-stub>
<body>
<p>
<named-content content-type="letter-date">20 Mar 2024</named-content>
</p>
<p>PONE-D-23-28781R2 </p>
<p>PLOS ONE</p>
<p>Dear Dr.  Khanduja, </p>
<p>I'm pleased to inform you that your manuscript has been deemed suitable for publication in PLOS ONE. Congratulations! Your manuscript is now being handed over to our production team.</p>
<p>At this stage, our production department will prepare your paper for publication. This includes ensuring the following:</p>
<p>* All references, tables, and figures are properly cited</p>
<p>* All relevant supporting information is included in the manuscript submission,</p>
<p>* There are no issues that prevent the paper from being properly typeset</p>
<p>If revisions are needed, the production department will contact you directly to resolve them. If no revisions are needed, you will receive an email when the publication date has been set. At this time, we do not offer pre-publication proofs to authors during production of the accepted work. Please keep in mind that we are working through a large volume of accepted articles, so please give us a few weeks to review your paper and let you know the next and final steps. </p>
<p>Lastly, if your institution or institutions have a press office, please let them know about your upcoming paper now to help maximize its impact. If they'll be preparing press materials, please inform our press team within the next 48 hours. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information, please contact <email xlink:type="simple">onepress@plos.org</email>.</p>
<p>If we can help with anything else, please email us at <email xlink:type="simple">customercare@plos.org</email>.</p>
<p>Thank you for submitting your work to PLOS ONE and supporting open access. </p>
<p>Kind regards, </p>
<p>PLOS ONE Editorial Office Staff</p>
<p>on behalf of</p>
<p>Dr. Joshua Robert Zadro </p>
<p>Academic Editor</p>
<p>PLOS ONE</p>
</body>
</sub-article>
</article>